rfhg_235635.1

Basic information about the TSS

---

TSS ID: rfhg_235635.1 Species: human Chr: chrX		Start: 47193705 End: 47193705 Strand: +
Source datasets	EPD
Protocol	TSS_database
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D4281772,EH38E2753556)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AK296866:114 GeneID: 7317 HGNC/MGI_ID: HGNC:12469 UniProt_ID: B4DL67 Nearer transcript ids and distances: ENST00000442035.5:124 ENST00000335972.11:124 NM_003334.4:124 AK293161:124 ENST00000457753.5:132 BC009900:139 LF379460:149 MA615037:149 M58028:191 HM005603:277 X56976:288 view more...

Gene_name: ubiquitin like modifier activating enzyme 1 Gene_symbol: UBA1 Gene_synonyms: CFAP124 POC20 UBE1X Gene_source: HGNC:12469

TATA-Box annotation

---

Distance to TSS:	-124
Nearest PromoterID:	NM_003334
Entrez ID:	7317
Nearest Unigene:	Hs.533273
Nearest Refseq:	NM_003334
Nearest Ensembl:	ENSG00000130985
Gene Name:	ubiquitin like modifier activating enzyme 1
Gene Alias:	A1S9|A1S9T|A1ST|AMCX1|CFAP124|GXP1|POC20|SMAX2|UBA1A|UBE1|UBE1X
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	1.000000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@UBA1 p2@UBA1 p3@UBA1 p4@UBA1 p5@UBA1
Sample		p1@UBA1	p2@UBA1	p3@UBA1	p4@UBA1	p5@UBA1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	149.02	87.66	1.36	5.84	1.56
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	151.74	85.58	2.23	5.46	0.81
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	147.76	85.65	2.89	8.68	0.96
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	137.64	92.31	2.49	6.45	0.83
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	151.40	86.39	1.12	5.85	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	151.75	93.61	1.55	8.33	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	132.47	143.80	3.05	10.46	1.53
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	135.16	115.30	2.42	9.69	1.94
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	135.50	133.57	2.78	9.19	1.71
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	166.35	122.88	3.48	4.64	2.32
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	181.10	122.08	2.43	6.47	1.62
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	177.26	97.17	2.03	3.25	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	51.42	9.67	1.93	3.87	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	56.08	9.92	2.10	3.76	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	53.79	6.81	1.54	4.83	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	43.26	10.56	1.26	4.28	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	44.99	8.30	3.71	4.37	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	41.76	12.65	1.27	3.37	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	51.72	7.46	2.13	3.20	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	43.63	7.07	2.11	4.51	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	48.78	7.08	2.27	3.07	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	49.03	8.98	1.90	2.93	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	49.63	9.69	3.49	3.49	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	49.50	11.89	2.18	5.82	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	51.60	8.77	1.81	4.13	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	56.34	8.23	1.90	3.48	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	46.15	7.14	2.75	2.20	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	57.05	9.19	2.59	6.13	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	40.54	7.43	3.39	3.23	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	43.79	8.32	1.45	3.80	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	38.94	7.75	1.26	4.19	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	32.82	8.21	1.37	5.67	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	35.45	6.75	2.32	4.85	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	55.42	8.58	2.47	4.95	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	43.76	7.67	2.24	4.67	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	40.24	9.20	0.77	4.22	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	50.07	6.95	1.43	3.47	1.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	42.92	8.66	2.01	3.43	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	47.27	9.72	1.62	4.86	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	39.61	6.48	3.36	3.84	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	42.35	6.35	3.29	4.23	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	50.36	6.00	2.93	3.51	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	43.44	13.29	2.11	3.80	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	45.28	8.57	2.97	3.85	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	44.17	6.42	3.01	3.81	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	45.60	8.38	2.09	3.02	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	41.26	11.04	1.44	5.04	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	47.39	11.33	2.09	4.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	36.62	8.86	5.03	3.83	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	35.99	10.11	1.82	3.24	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	62.72	8.61	4.30	2.87	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	52.04	10.45	2.67	3.56	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	167.91	0.00	0.00	27.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	41.16	8.16	1.42	3.90	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	40.10	14.91	1.99	6.30	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	76.34	5.03	2.52	4.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	82.66	10.10	4.13	2.76	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	38.24	17.83	2.92	5.83	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	29.87	14.13	1.93	6.42	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	85.18	14.14	2.51	4.71	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	33.14	13.40	2.82	4.23	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	39.82	11.22	1.68	5.05	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	97.93	10.35	4.78	3.98	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	54.02	13.25	3.06	6.12	1.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	23.07	23.72	2.92	8.12	2.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	34.43	17.39	2.13	6.74	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	80.82	32.33	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	86.87	7.90	0.00	7.90	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	36.08	22.43	3.41	2.44	3.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	41.65	21.32	3.47	3.47	1.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	32.84	17.83	2.81	3.75	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	53.65	22.52	1.32	3.64	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	22.89	26.91	1.55	4.95	3.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	32.71	21.71	3.06	5.50	1.53
Adipocyte - breast, donor1	11376-118A8	129.40	16.16	5.86	3.17	3.64
Adipocyte - breast, donor2	11327-117E4	85.51	8.02	6.10	2.41	2.09
Adipocyte - omental, donor1	11473-119C6	129.01	14.38	7.12	3.82	2.42
Adipocyte - omental, donor2	11474-119C7	107.64	6.73	6.73	0.75	3.74
Adipocyte - omental, donor3	11475-119C8	69.66	7.37	4.69	2.01	1.67
Adipocyte - perirenal, donor1	11476-119C9	95.06	10.85	5.74	3.19	3.19
Adipocyte - subcutaneous, donor1	11259-116F8	37.38	4.40	2.20	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	114.26	25.74	4.97	3.16	2.71
Adipocyte - subcutaneous, donor3	11408-118E4	78.55	6.26	3.30	3.48	0.70
Adipocyte differentiation, day04, donor1	13019-139D4	95.63	5.48	5.48	2.15	1.37
Adipocyte differentiation, day04, donor2	13022-139D7	82.88	6.43	5.40	2.57	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	93.95	6.69	4.46	1.67	1.12
Adipocyte differentiation, day04, donor4	13028-139E4	93.46	4.11	5.29	1.18	2.35
Adipocyte differentiation, day08, donor1	13020-139D5	109.07	3.38	6.43	2.41	0.48
Adipocyte differentiation, day08, donor2	13023-139D8	78.75	3.87	3.23	3.23	1.29
Adipocyte differentiation, day08, donor3	13026-139E2	83.71	2.67	4.80	2.13	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	81.24	1.11	2.78	1.11	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	84.01	2.91	4.57	1.25	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	68.07	2.76	3.01	1.00	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	78.21	3.60	5.24	1.96	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	68.81	0.91	4.87	1.52	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	202.65	37.79	6.85	6.63	1.55
Alveolar Epithelial Cells, donor2	11590-120G6	149.89	37.65	5.02	7.17	2.15
Alveolar Epithelial Cells, donor3	11671-122G6	105.43	13.18	5.99	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	139.43	17.45	3.24	3.78	0.90
Amniotic Epithelial Cells, donor2	11613-122A2	132.21	8.37	3.35	3.35	3.35
Amniotic Epithelial Cells, donor3	11694-123A2	126.76	21.98	5.75	2.47	2.26
Anulus Pulposus Cell, donor1	11248-116E6	142.92	13.73	7.90	5.72	2.29
Anulus Pulposus Cell, donor2	11463-119B5	99.92	7.59	7.10	2.20	3.67
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	88.51	9.88	3.59	3.15	1.80
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	90.30	15.63	4.78	2.60	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	74.91	12.84	6.42	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	72.64	7.77	6.88	2.09	2.39
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	88.53	10.12	2.53	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	64.69	10.56	5.28	1.98	3.96
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	83.17	11.70	3.57	1.95	2.27
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	83.50	8.74	3.40	2.43	1.94
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	87.30	7.72	5.94	1.78	2.97
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	89.26	9.42	6.40	2.64	2.26
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	93.61	5.81	4.35	3.63	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	66.45	11.28	5.02	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	91.43	9.06	5.44	1.98	1.65
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	49.13	13.65	6.82	1.36	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	57.60	10.86	2.41	2.87	1.51
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	84.12	9.64	2.68	3.75	3.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	70.85	7.94	3.78	1.89	0.94
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	73.77	12.83	6.68	1.60	1.60
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	79.01	11.71	3.90	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	67.17	8.29	4.48	2.16	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	80.45	8.41	2.40	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	77.88	10.62	10.62	0.00	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	65.01	9.43	5.49	2.23	1.89
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	67.12	8.39	0.00	0.00	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	90.77	8.25	5.34	2.43	2.91
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	80.06	7.21	4.55	1.90	1.52
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	67.84	14.54	4.85	4.85	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	79.23	11.97	5.13	1.14	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	72.68	11.54	3.42	1.71	1.50
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	54.97	10.07	6.45	2.84	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	91.03	12.20	5.63	5.63	1.41
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	72.99	7.72	3.54	0.96	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	71.35	15.70	6.42	4.99	2.14
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	73.70	7.02	7.60	1.75	2.92
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	67.14	8.43	3.61	2.41	1.51
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	83.16	17.82	9.50	1.19	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	100.19	7.12	3.56	1.53	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	82.01	8.40	5.60	1.78	1.78
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	63.54	8.90	1.91	1.91	2.54
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	84.58	8.63	6.47	2.59	1.73
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	69.86	9.53	4.66	1.91	1.91
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	55.68	11.89	2.90	1.45	0.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	76.52	4.72	7.56	1.89	5.67
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	63.74	8.48	5.09	2.20	2.03
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	67.17	11.58	9.27	2.32	9.27
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	82.39	23.24	6.34	4.23	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	77.19	8.58	5.15	3.22	0.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	61.97	11.43	7.82	1.80	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	87.48	4.37	0.73	2.19	2.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	78.62	8.97	5.06	0.92	1.84
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	61.21	12.75	5.10	2.55	7.65
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	65.08	13.73	2.80	1.78	2.80
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	77.83	9.29	3.92	3.10	1.03
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	73.75	8.26	3.98	1.84	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	94.65	7.65	4.78	3.82	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	75.61	9.98	4.66	2.00	2.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	44.25	9.15	4.58	0.00	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	86.41	8.86	3.88	2.22	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	86.06	6.62	4.77	1.32	1.59
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	66.51	9.45	4.72	2.18	1.45
Astrocyte - cerebellum, donor1	11500-119F6	283.21	26.65	13.26	7.25	2.21
Astrocyte - cerebellum, donor2	11580-120F5	239.45	20.71	14.04	7.87	3.59
Astrocyte - cerebellum, donor3	11661-122F5	159.83	7.97	10.49	5.03	1.26
Astrocyte - cerebral cortex, donor1	11235-116D2	170.81	13.25	6.62	7.67	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	161.13	24.59	7.77	6.96	0.65
Astrocyte - cerebral cortex, donor3	11392-118C6	132.01	15.36	3.73	7.61	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	85.21	114.34	5.28	15.02	6.65
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	84.06	111.75	5.76	18.29	4.89
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	82.96	121.88	5.58	17.07	6.15
Basophils, donor1	12241-129G9	88.14	2.09	6.02	0.78	0.78
Basophils, donor2	12242-129H1	66.75	7.58	4.69	1.44	2.89
Basophils, donor3	12243-129H2	48.07	2.50	3.53	1.91	1.03
Bronchial Epithelial Cell, donor1	11511-119G8	147.69	24.79	5.82	4.53	1.72
Bronchial Epithelial Cell, donor2	11591-120G7	150.41	39.78	14.17	10.06	1.37
Bronchial Epithelial Cell, donor3	11672-122G7	100.43	7.17	21.52	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	89.75	42.05	5.65	6.28	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	170.10	46.58	9.77	8.11	1.04
Bronchial Epithelial Cell, donor6	11461-119B3	142.78	25.10	6.91	4.38	2.07
Bronchial Epithelial Cell, donor7	11769-123I5	64.96	18.17	2.34	1.26	0.72
Burkitt's lymphoma cell line:DAUDI	10422-106C8	77.81	47.10	3.30	3.71	5.05
Burkitt's lymphoma cell line:RAJI	10476-106I8	50.07	107.37	1.40	9.78	4.89
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	65.55	41.89	1.92	4.16	3.20
CD133+ stem cells - cord blood derived, pool1	12223-129E9	217.18	31.03	0.00	0.00	10.34
CD14+ Monocytes, donor1	11224-116B9	89.61	2.82	3.94	2.82	0.00
CD14+ Monocytes, donor2	11305-117B9	92.99	3.34	4.83	2.04	0.74
CD14+ Monocytes, donor3	11381-118B4	88.69	3.73	5.71	1.10	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	93.97	5.38	8.21	3.96	1.98
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	79.23	3.79	7.96	4.93	2.65
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	79.23	5.26	6.25	3.62	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	80.37	1.01	5.93	0.58	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	59.44	0.91	2.72	0.60	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	65.38	0.00	4.74	0.47	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	72.65	0.33	3.68	0.67	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	67.62	0.55	2.48	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	87.27	0.25	3.72	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	84.19	0.59	2.74	0.39	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	58.40	0.89	2.85	0.71	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	78.56	0.44	3.26	0.44	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	127.36	1.64	4.21	0.47	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	113.00	0.53	2.11	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	130.90	0.00	5.55	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	76.46	0.89	3.57	0.45	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	67.85	0.00	2.79	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	67.25	0.62	2.71	0.42	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	133.38	0.23	4.58	0.69	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	111.74	0.23	2.26	0.23	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	117.84	0.44	2.18	0.44	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	78.81	0.54	5.11	0.54	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	66.47	0.70	4.19	0.52	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	71.96	0.84	2.10	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	118.68	0.37	4.96	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	103.21	0.70	1.76	0.35	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	143.46	0.44	3.07	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	83.35	0.17	3.66	0.87	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	73.96	0.37	3.72	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	84.71	0.86	2.59	1.08	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	113.02	0.82	7.37	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	95.04	0.93	2.55	0.70	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	94.88	0.00	2.78	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	86.97	2.83	4.80	1.96	1.31
CD14+CD16+ Monocytes, donor2	11801-124D1	86.39	2.08	6.01	2.08	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	74.95	2.82	3.90	0.87	1.08
CD14+CD16- Monocytes, donor1	11788-124B6	109.78	1.87	6.85	1.87	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	88.89	4.72	4.54	2.97	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	103.01	2.23	5.80	2.90	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	76.81	1.02	4.34	0.77	1.02
CD14-CD16+ Monocytes, donor2	11800-124C9	95.29	1.10	5.71	1.32	1.10
CD14-CD16+ Monocytes, donor3	11911-125G3	95.80	3.16	5.47	2.74	1.68
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	99.58	12.19	6.10	12.19	6.10
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	133.56	12.88	7.46	6.10	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	84.92	18.64	4.14	1.04	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	92.75	17.59	5.86	6.93	4.26
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	104.53	16.62	2.68	5.90	4.29
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	112.31	15.44	9.13	3.51	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	117.65	18.04	8.63	2.35	3.92
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	143.69	15.82	3.95	2.64	0.00
CD19+ B Cells, donor1	11544-120B5	120.82	16.44	4.93	3.29	3.29
CD19+ B Cells, donor2	11624-122B4	86.33	17.41	5.08	2.18	0.73
CD19+ B Cells, donor3	11705-123B4	76.23	12.12	6.06	5.05	4.04
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	82.02	16.16	6.87	3.64	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	59.92	17.18	2.80	6.39	0.80
CD34+ Progenitors, donor1	11545-120B6	40.16	9.04	0.00	4.02	1.00
CD34+ Progenitors, donor2	11625-122B5	61.80	5.62	0.56	0.56	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	80.79	35.70	2.63	4.88	3.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	93.58	48.25	3.38	5.19	4.28
CD4+ T Cells, donor1	11225-116C1	85.34	7.14	5.71	0.36	1.07
CD4+ T Cells, donor2	11306-117C1	72.87	12.86	5.51	1.22	3.67
CD4+ T Cells, donor3	11382-118B5	69.23	7.93	5.79	0.61	2.74
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	95.97	18.63	4.85	3.06	5.87
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	91.86	18.42	5.61	3.14	7.19
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	79.91	16.67	7.19	1.44	2.59
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	87.23	10.43	5.22	1.90	2.37
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	94.11	7.02	2.81	1.40	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	72.52	6.59	9.89	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	81.07	14.60	6.50	1.73	4.62
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	63.04	26.94	6.44	2.88	6.44
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	60.13	21.28	7.42	3.22	5.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	81.59	8.97	6.72	1.34	2.69
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	88.74	10.13	6.64	1.40	2.10
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	110.88	14.96	7.04	1.76	1.76
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	92.76	23.19	4.22	1.69	6.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	49.86	19.53	3.32	1.87	4.16
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	55.80	19.71	3.01	2.34	6.01
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	103.34	12.78	3.54	0.27	3.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	111.48	8.58	2.68	1.61	3.75
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	107.59	17.93	5.38	1.79	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	84.56	26.15	6.12	3.15	4.82
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	66.93	24.48	3.25	2.60	4.55
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	78.60	21.65	3.78	2.73	4.41
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	77.86	10.11	2.53	0.00	2.02
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	84.48	10.40	4.77	0.87	2.17
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	114.18	11.77	5.23	0.87	2.61
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	123.22	13.86	10.89	2.47	4.45
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	94.16	6.46	4.62	0.92	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	93.52	8.37	11.17	4.19	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	116.03	12.74	8.86	1.38	2.49
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	111.90	10.80	11.29	2.94	4.66
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	121.66	9.24	3.08	3.08	3.08
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	132.15	13.25	7.88	2.51	4.30
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	128.80	19.39	9.69	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	62.21	9.17	4.26	1.96	1.31
CD8+ T Cells, donor2	11307-117C2	51.06	8.26	3.00	2.25	3.00
CD8+ T Cells, donor3	11383-118B6	62.62	6.82	5.05	0.25	2.78
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	37.62	16.52	2.29	3.44	3.44
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	43.85	19.17	2.40	2.64	3.35
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	40.49	16.96	2.19	2.19	1.64
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	42.03	21.01	1.50	3.90	3.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	42.48	15.12	3.84	2.64	2.64
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	38.66	17.05	0.91	2.96	2.27
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	46.28	26.29	2.39	4.78	2.61
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	48.43	25.53	1.84	3.95	4.47
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	56.52	28.14	1.41	4.46	2.81
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	63.39	21.74	2.72	4.23	3.92
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	52.87	28.76	1.45	4.07	3.49
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	47.43	22.91	2.93	4.26	2.13
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	57.35	8.32	2.19	0.88	2.19
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	52.37	10.02	2.28	0.91	1.82
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	26.85	8.95	0.75	0.00	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	50.78	10.08	1.80	3.24	1.80
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	48.05	13.52	1.15	3.45	0.86
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	34.18	10.61	2.12	2.83	1.65
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	52.61	18.38	4.12	4.75	4.12
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	46.13	21.53	1.23	4.00	3.38
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	55.78	18.91	2.24	5.13	2.24
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	49.34	22.95	3.82	2.68	2.29
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	44.14	17.73	2.36	2.36	1.97
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	52.19	23.45	0.00	5.29	2.27
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	84.31	12.04	4.82	0.00	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	67.84	11.19	4.20	1.40	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	99.17	11.02	3.01	0.00	5.01
Cardiac Myocyte, donor1	11525-119I4	297.92	7.31	1.83	10.97	0.00
Cardiac Myocyte, donor2	11605-120I3	98.82	13.34	2.96	1.98	1.98
Cardiac Myocyte, donor3	11686-122I3	92.92	12.31	2.42	3.58	1.05
Chondrocyte - de diff, donor1	11261-116G1	82.16	12.13	4.16	1.73	2.77
Chondrocyte - de diff, donor2	11338-117F6	100.93	8.53	4.62	3.20	2.49
Chondrocyte - de diff, donor3	11410-118E6	55.98	6.14	3.41	2.28	0.91
Chondrocyte - re diff, donor2	11339-117F7	67.14	5.37	0.90	0.90	2.69
Chondrocyte - re diff, donor3	11411-118E7	67.54	8.49	4.04	1.62	3.24
Ciliary Epithelial Cells, donor1	11242-116D9	201.74	16.07	9.98	5.97	1.61
Ciliary Epithelial Cells, donor2	11323-117D9	115.43	12.83	5.13	4.06	1.28
Ciliary Epithelial Cells, donor3	11399-118D4	150.18	12.74	8.85	4.16	1.15
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	156.72	12.56	8.16	3.67	1.56
Corneal Epithelial Cells, donor1	11526-119I5	136.35	36.23	4.39	4.83	2.20
Corneal Epithelial Cells, donor2	11606-120I4	128.55	27.30	4.55	2.28	0.00
Corneal Epithelial Cells, donor3	11687-122I4	93.31	33.74	3.07	7.41	1.79
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	92.62	2.97	6.11	2.64	1.65
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	82.01	2.84	7.89	2.84	1.26
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	79.37	6.90	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	53.02	2.70	3.46	3.46	2.16
Dendritic Cells - plasmacytoid, donor1	11228-116C4	92.93	10.25	4.44	1.71	1.71
Dendritic Cells - plasmacytoid, donor2	11309-117C4	70.51	9.79	1.31	1.96	1.96
Dendritic Cells - plasmacytoid, donor3	11385-118B8	90.50	7.26	5.32	3.39	2.90
Endothelial Cells - Aortic, donor0	11207-116A1	136.92	20.85	4.34	5.84	1.50
Endothelial Cells - Aortic, donor1	11263-116G3	126.74	21.71	6.45	0.59	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	161.76	20.93	4.24	3.39	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	109.31	16.51	7.08	3.15	1.18
Endothelial Cells - Artery, donor1	11264-116G4	109.08	16.58	7.56	3.78	1.45
Endothelial Cells - Artery, donor2	11341-117F9	93.88	25.65	4.94	6.12	1.18
Endothelial Cells - Artery, donor3	11413-118E9	128.85	31.38	6.66	6.31	1.93
Endothelial Cells - Lymphatic, donor1	11236-116D3	87.77	13.74	5.76	2.44	1.11
Endothelial Cells - Lymphatic, donor2	11317-117D3	77.28	9.13	4.56	4.56	0.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	80.91	7.89	3.10	3.10	0.85
Endothelial Cells - Microvascular, donor1	11265-116G5	147.68	13.07	8.32	5.65	0.89
Endothelial Cells - Microvascular, donor2	11342-117G1	123.92	21.35	3.64	3.64	2.60
Endothelial Cells - Microvascular, donor3	11414-118F1	68.91	5.96	4.96	2.98	0.99
Endothelial Cells - Thoracic, donor1	11266-116G6	169.65	29.21	6.80	8.40	2.00
Endothelial Cells - Thoracic, donor2	11343-117G2	90.15	17.82	1.57	3.67	2.10
Endothelial Cells - Umbilical vein, donor1	11243-116E1	127.10	32.43	5.34	7.58	1.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	78.21	14.34	1.74	4.13	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	81.21	17.83	4.27	4.03	0.85
Endothelial Cells - Vein, donor1	11267-116G7	122.85	30.71	5.69	6.83	1.14
Endothelial Cells - Vein, donor2	11344-117G3	197.68	34.93	4.19	8.38	1.40
Endothelial Cells - Vein, donor3	11416-118F3	138.79	24.18	8.01	7.07	1.26
Eosinophils, donor1	12244-129H3	60.99	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	206.28	0.00	13.20	0.00	0.00
Eosinophils, donor3	12246-129H5	203.31	0.00	7.13	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	115.32	37.14	4.64	6.11	0.98
Esophageal Epithelial Cells, donor2	11587-120G3	108.17	29.12	8.32	2.08	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	97.61	16.27	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	89.90	8.62	6.16	2.05	1.23
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	35.80	8.32	2.52	1.09	1.42
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	52.98	7.80	3.79	2.82	1.52
Fibroblast - Aortic Adventitial, donor1	11245-116E3	153.66	18.68	7.16	5.09	2.18
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	185.19	25.52	9.28	5.60	3.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	76.15	10.13	4.85	2.64	1.27
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	183.39	17.39	7.90	7.64	2.37
Fibroblast - Aortic Adventitial, donor3	11401-118D6	98.33	14.62	5.65	4.65	2.66
Fibroblast - Cardiac, donor1	11268-116G8	71.22	11.79	2.72	1.81	0.91
Fibroblast - Cardiac, donor2	11345-117G4	233.45	25.77	12.89	7.58	0.76
Fibroblast - Cardiac, donor3	11417-118F4	67.19	6.15	3.63	1.58	1.73
Fibroblast - Cardiac, donor4	11452-119A3	84.87	9.40	3.94	5.15	0.91
Fibroblast - Cardiac, donor5	11456-119A7	66.37	10.66	4.19	3.43	1.52
Fibroblast - Cardiac, donor6	11460-119B2	71.25	15.31	3.34	3.34	1.21
Fibroblast - Choroid Plexus, donor1	11492-119E7	144.84	12.33	5.63	4.15	2.55
Fibroblast - Choroid Plexus, donor2	11572-120E6	122.09	13.81	3.45	3.88	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	92.28	35.16	4.39	5.86	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	272.85	22.83	7.38	9.23	2.77
Fibroblast - Conjunctival, donor3	11692-122I9	136.02	11.53	8.82	3.73	2.20
Fibroblast - Dermal, donor1	11269-116G9	57.99	16.90	3.52	2.82	1.64
Fibroblast - Dermal, donor2	11346-117G5	183.48	25.94	7.08	2.36	4.72
Fibroblast - Dermal, donor3	11418-118F5	79.91	11.85	6.65	5.20	2.54
Fibroblast - Dermal, donor4	11450-119A1	96.88	23.63	8.03	7.57	2.03
Fibroblast - Dermal, donor5	11454-119A5	84.09	30.01	6.11	7.68	1.22
Fibroblast - Dermal, donor6	11458-119A9	90.14	32.48	5.52	8.77	3.09
Fibroblast - Gingival, donor1	11237-116D4	109.11	19.57	3.54	3.33	1.87
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	122.09	12.31	7.34	2.10	1.57
Fibroblast - Gingival, donor2	11318-117D4	89.35	26.49	5.01	7.12	1.45
Fibroblast - Gingival, donor3	11394-118C8	81.22	10.54	4.35	3.19	2.22
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	93.50	11.43	5.19	2.08	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	62.38	6.87	4.23	1.76	1.23
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	163.22	19.02	9.04	6.39	1.71
Fibroblast - Gingival, donor6 (control)	11922-125H5	142.39	13.39	7.98	5.00	2.16
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	171.85	11.65	12.00	3.53	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	133.08	17.26	8.77	4.83	3.07
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	113.58	18.95	7.64	2.59	2.32
Fibroblast - Gingival, donor8 (control)	11926-125H9	94.12	16.78	5.05	3.73	1.54
Fibroblast - Gingival, donor9 (control)	11927-125I1	124.87	8.07	8.07	2.20	1.32
Fibroblast - Lung, donor1	11270-116H1	134.58	17.67	9.52	9.52	2.72
Fibroblast - Lung, donor2	11347-117G6	123.85	20.89	2.98	10.45	2.98
Fibroblast - Lung, donor3	11419-118F6	83.15	16.67	4.01	7.60	1.69
Fibroblast - Lymphatic, donor1	11506-119G3	314.88	48.32	11.66	5.00	6.66
Fibroblast - Lymphatic, donor2	11586-120G2	79.72	12.59	11.19	1.40	2.80
Fibroblast - Lymphatic, donor3	11667-122G2	146.93	15.95	8.12	3.64	3.36
Fibroblast - Mammary, donor1	11540-120B1	285.80	52.37	12.18	13.80	4.87
Fibroblast - Mammary, donor2	11620-122A9	195.72	47.93	15.98	15.98	0.00
Fibroblast - Mammary, donor3	11701-123A9	113.17	11.91	17.87	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	116.19	29.29	5.63	7.76	1.36
Fibroblast - Periodontal Ligament, donor2	11319-117D5	132.27	25.63	6.83	7.58	1.97
Fibroblast - Periodontal Ligament, donor3	11395-118C9	105.57	21.11	3.67	5.20	1.22
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	126.70	10.69	7.25	3.05	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	100.44	12.69	6.21	2.43	1.89
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	65.87	6.03	4.18	2.44	1.04
Fibroblast - Pulmonary Artery, donor1	11250-116E8	89.42	22.99	4.31	5.08	1.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	244.64	25.81	12.19	4.27	2.84
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	123.62	26.73	4.68	6.68	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	77.89	11.86	3.16	5.14	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	315.93	36.32	18.26	7.94	3.97
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	96.80	6.93	4.26	2.49	1.60
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	90.07	10.05	2.37	3.94	2.56
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	196.76	45.13	10.83	8.42	3.61
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	125.66	11.23	5.51	2.59	1.51
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	235.11	25.05	11.89	8.10	5.31
Fibroblast - skin normal, donor1	11553-120C5	127.16	12.96	5.25	1.97	1.97
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	204.12	44.71	11.23	8.22	5.01
Fibroblast - skin normal, donor2	11561-120D4	118.95	12.36	4.32	3.52	2.11
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	270.20	35.97	12.09	8.16	4.53
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	90.39	8.04	3.81	2.65	1.99
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	107.53	8.21	5.47	4.27	2.56
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	201.66	19.71	5.58	6.90	3.94
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	138.05	13.74	7.78	3.52	1.81
Fibroblast - skin walker warburg, donor1	11554-120C6	150.80	20.41	5.74	4.22	2.02
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	74.18	6.90	3.45	1.25	0.94
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	265.92	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	87.15	9.59	2.61	6.97	2.61
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	150.47	22.54	8.49	2.60	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	129.86	27.85	7.29	5.47	2.34
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	81.00	16.86	2.04	3.58	1.79
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	104.88	32.15	4.59	6.89	2.30
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	121.87	37.01	0.64	11.49	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	136.93	77.88	3.99	18.54	1.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	205.16	13.51	8.27	7.72	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	126.04	16.67	5.71	7.76	1.37
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	115.71	46.96	3.96	12.09	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	174.99	18.50	6.87	8.46	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	107.30	13.05	8.81	7.50	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	134.44	71.64	4.86	22.55	2.21
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	231.77	26.14	5.37	9.33	0.57
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	220.55	21.92	8.37	6.90	1.23
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	160.64	22.30	6.72	6.72	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	231.56	22.80	6.81	7.56	2.11
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	236.99	18.96	8.72	8.17	1.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	152.27	19.52	3.25	6.51	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	189.84	23.05	8.44	3.65	2.97
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	242.16	19.18	10.09	4.48	2.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	184.26	15.74	7.87	6.78	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	195.02	29.25	4.73	5.91	1.18
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	254.65	20.35	8.11	6.99	3.02
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	181.86	26.59	5.59	5.81	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	209.09	32.66	6.65	7.86	3.43
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	260.40	22.90	7.12	8.48	2.54
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	274.88	42.47	9.84	9.13	2.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	268.67	58.69	6.04	16.96	5.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	274.27	47.82	6.66	15.03	4.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	230.71	21.25	8.41	9.18	2.99
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	253.42	39.85	7.15	9.07	3.58
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	303.82	41.45	4.49	8.78	2.86
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	194.13	30.74	7.43	9.70	2.68
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	253.07	25.71	8.30	8.53	3.34
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	177.27	31.35	7.50	9.84	2.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	187.37	26.45	10.14	10.80	2.87
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	249.18	23.98	7.26	10.58	4.55
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	196.78	25.12	8.10	8.75	2.11
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	210.39	26.30	7.06	9.94	3.85
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	228.83	24.16	9.48	10.04	3.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	161.02	28.47	6.01	9.49	2.06
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	232.02	29.50	5.78	8.21	2.74
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	212.42	24.25	9.41	10.14	2.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	158.52	20.86	6.59	6.15	4.17
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	195.26	27.49	7.01	10.38	2.24
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	214.99	21.39	12.04	7.41	3.33
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	148.94	29.95	5.08	8.82	4.01
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	169.38	31.06	8.26	7.04	3.83
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	187.57	22.41	7.25	6.74	3.37
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	144.48	23.85	5.42	5.96	2.98
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	170.71	29.31	6.08	6.27	3.50
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	178.30	22.15	7.68	7.46	3.51
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	189.42	22.81	5.95	6.94	3.97
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	162.78	22.56	6.46	6.86	3.69
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	177.14	23.61	7.26	7.67	3.03
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	289.49	56.68	11.69	21.60	10.17
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	359.50	52.35	9.55	16.32	2.99
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	248.99	29.12	6.78	9.86	1.69
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	316.29	30.07	9.41	15.75	1.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	93.88	30.35	1.88	10.95	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	94.66	29.10	2.26	7.91	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	122.68	19.37	3.69	8.76	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	116.32	17.32	0.00	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	107.15	20.89	2.71	4.25	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	72.20	6.42	1.60	8.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	170.41	22.60	3.48	8.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	103.18	10.74	2.60	1.95	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	112.83	14.82	2.06	4.12	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	79.97	19.99	0.00	6.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	104.03	13.70	2.80	3.36	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	97.73	15.03	3.27	7.52	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	102.34	24.33	2.52	1.68	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	130.41	12.09	1.91	6.04	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	108.35	14.61	2.38	5.43	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	87.70	12.53	0.00	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	150.05	15.46	1.15	2.29	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	96.79	9.18	4.44	5.62	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	98.26	10.16	3.39	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	135.45	12.84	3.31	2.07	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	109.77	13.12	4.37	2.76	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	105.37	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	114.94	10.38	2.31	3.46	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	74.97	8.48	1.63	2.61	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	56.18	4.68	2.01	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	115.58	10.40	1.54	5.39	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	114.68	15.41	1.03	2.40	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	144.12	17.39	9.94	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	77.38	11.80	1.89	4.25	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	91.73	6.64	2.41	7.24	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	94.10	9.66	3.05	2.03	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	97.72	9.17	1.60	3.99	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	116.43	9.37	0.99	2.96	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	118.04	15.35	0.00	4.72	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	106.19	11.67	1.17	5.25	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	106.65	11.85	2.19	5.71	1.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	104.27	7.63	0.85	7.63	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	97.89	13.13	2.39	1.19	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	102.39	8.25	2.91	0.97	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	132.39	15.98	4.57	4.57	2.28
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	99.80	9.56	6.24	3.74	3.33
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	157.42	17.99	23.61	6.75	3.37
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	72.63	8.25	2.85	2.54	3.49
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	69.35	10.44	2.51	1.25	1.25
Hep-2 cells mock treated, biol_rep1	11898-125E8	83.09	21.93	4.99	7.54	0.58
Hep-2 cells mock treated, biol_rep2	11899-125E9	95.20	25.32	2.70	5.74	0.84
Hep-2 cells mock treated, biol_rep3	11900-125F1	87.82	20.70	5.23	6.37	1.14
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	85.37	21.42	3.72	6.89	0.98
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	103.80	29.01	4.08	7.74	2.15
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	90.20	23.25	4.31	7.97	1.29
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	79.83	19.93	5.48	6.73	1.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	80.63	19.39	4.46	8.06	0.69
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	84.90	23.39	3.84	3.52	0.96
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	145.50	12.87	6.72	3.36	2.80
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	164.89	27.70	6.49	6.49	1.73
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	89.89	29.08	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	180.95	21.52	2.82	5.64	1.76
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	155.47	19.62	9.44	5.81	2.91
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	77.10	22.90	2.97	3.50	2.10
Hepatocyte, donor1	11523-119I2	162.22	6.05	10.90	1.21	0.00
Hepatocyte, donor2	11603-120I1	148.67	2.15	4.31	0.00	1.08
Hepatocyte, donor3	11684-122I1	134.98	6.14	6.75	1.84	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	50.91	134.45	1.96	7.18	8.48
Intestinal epithelial cells (polarized), donor1	11246-116E4	115.71	11.71	1.92	3.67	1.57
Iris Pigment Epithelial Cells, donor1	11530-119I9	137.21	14.27	7.68	4.94	0.96
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	120.99	25.47	9.55	15.92	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	46.73	6.68	0.00	13.35	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	162.50	54.17	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	81.68	31.84	13.84	9.69	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	112.62	22.52	2.50	15.02	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	154.29	23.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	102.52	20.50	7.69	12.81	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	123.41	27.42	9.14	13.71	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	115.33	42.23	14.62	12.99	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	90.03	36.68	6.67	5.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	87.13	10.89	3.63	7.26	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	93.97	23.82	10.59	13.23	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	93.13	23.28	7.76	9.98	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	115.24	15.71	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	81.25	24.56	12.60	8.19	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	74.24	13.92	3.09	4.64	3.09
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	29.27	14.63	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	107.24	20.03	12.27	12.92	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	120.74	40.25	6.44	11.27	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	95.59	23.90	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	131.20	24.45	7.33	10.59	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	170.02	38.20	5.88	13.01	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	57.49	0.00	14.37	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	125.37	30.54	6.43	8.84	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	96.02	33.24	6.46	8.31	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	90.48	15.08	0.00	15.08	15.08
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	93.94	19.83	5.66	6.61	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	91.61	17.23	6.35	9.07	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	138.82	18.29	7.53	6.46	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	148.64	27.95	13.98	8.89	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	131.44	16.43	0.00	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	149.85	24.23	13.39	6.38	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	114.83	41.92	9.11	14.58	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	15.80	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	129.25	31.42	12.14	12.14	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	159.28	46.46	0.00	3.32	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	41.70	20.85	41.70	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	98.15	22.84	6.48	7.41	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	86.05	33.36	8.78	8.78	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	113.15	31.43	9.43	9.43	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	131.43	31.29	12.52	9.04	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	137.21	50.90	6.64	13.28	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	110.23	25.94	6.48	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	99.40	23.54	8.72	9.59	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	112.49	24.75	2.25	18.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	76.66	17.42	3.48	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	116.28	18.14	5.33	10.67	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	88.67	30.48	5.54	9.70	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	128.23	25.65	2.85	5.70	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	108.61	24.85	8.28	12.89	2.76
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	72.61	12.10	12.10	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	99.34	6.21	0.00	12.42	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	112.08	8.46	11.63	4.23	0.00
Keratinocyte - epidermal, donor1	11272-116H3	144.84	45.04	6.85	6.36	2.45
Keratinocyte - epidermal, donor2	11349-117G8	149.92	15.23	7.61	4.10	0.59
Keratinocyte - epidermal, donor3	11421-118F8	74.40	22.15	4.07	4.64	1.04
Keratinocyte - oral, donor1	11251-116E9	198.88	49.83	8.29	9.76	3.63
Keratocytes, donor1	11527-119I6	311.86	19.25	7.91	5.16	1.03
Keratocytes, donor2	11607-120I5	147.65	19.92	5.86	3.52	2.34
Keratocytes, donor3	11688-122I5	79.24	9.09	4.15	4.35	0.99
Krukenberg tumor cell line:HSKTC	10687-109F3	153.85	4.40	24.18	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	116.50	19.42	9.71	3.24	2.16
Lens Epithelial Cells, donor2	11609-120I7	155.12	10.03	6.23	6.23	1.04
Lens Epithelial Cells, donor3	11690-122I7	91.12	10.49	4.34	3.13	1.92
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	86.68	18.62	5.10	4.27	2.02
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	41.30	11.72	1.12	1.67	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	71.31	14.48	3.78	3.15	2.68
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	53.23	10.22	1.08	1.61	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	56.10	9.77	2.84	2.21	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	55.85	12.51	3.99	3.34	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	55.40	7.39	2.05	1.23	1.23
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	41.21	14.41	1.77	1.26	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	59.40	9.43	3.52	2.11	1.69
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	35.99	10.68	1.19	1.98	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	33.54	10.28	0.97	2.52	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	59.25	14.07	4.63	1.67	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	34.15	12.19	1.05	2.79	1.39
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	40.31	11.69	1.67	0.48	1.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	56.45	12.22	1.65	4.12	1.24
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	37.26	6.47	1.54	0.92	2.16
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	40.21	11.53	3.43	0.94	0.94
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	69.72	12.26	3.84	3.11	1.46
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	44.10	13.16	1.97	2.63	1.97
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	37.49	9.37	2.05	2.05	1.76
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	69.20	10.46	6.22	1.99	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	37.34	12.12	1.45	1.45	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	22.35	8.08	0.00	2.15	1.35
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	56.62	12.26	3.33	2.57	1.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	32.66	6.74	1.04	2.07	1.56
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	27.01	11.73	0.84	2.51	0.84
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	57.29	13.83	3.76	2.56	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	34.39	8.25	2.06	2.06	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	27.85	9.03	0.94	3.01	1.32
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	52.38	10.07	2.65	2.23	1.17
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	40.70	10.18	1.45	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	27.12	7.61	0.33	1.65	2.65
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	61.20	12.14	2.23	2.97	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	69.97	8.14	1.11	1.85	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	22.24	10.62	0.25	2.47	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	54.03	12.51	3.16	2.47	0.55
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	43.10	9.33	0.64	1.29	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	28.61	7.91	2.43	1.52	2.13
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	63.96	11.06	2.80	1.54	2.24
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	45.51	7.82	1.78	1.42	1.78
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	17.45	9.21	0.00	2.42	1.94
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	63.49	12.45	2.96	4.51	1.71
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	45.84	5.73	2.15	1.79	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	19.93	6.53	0.33	1.96	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	60.74	9.65	4.00	1.41	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	61.38	17.08	2.35	3.71	2.35
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	19.72	9.73	1.79	1.28	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	45.65	8.35	1.49	2.39	0.90
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	160.89	11.33	6.80	0.00	4.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	95.89	7.67	2.30	3.07	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	132.12	10.39	1.48	5.94	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	146.40	9.31	5.08	4.23	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	116.05	7.03	3.52	2.81	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	113.01	9.34	5.60	0.93	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	130.36	10.82	5.67	2.06	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	108.24	9.52	4.76	2.38	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	168.74	7.01	4.07	3.85	2.94
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	110.81	5.53	4.07	3.49	1.16
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	108.49	7.20	4.95	2.25	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	199.30	9.89	7.59	6.37	2.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	148.92	12.84	7.19	5.65	1.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	106.56	4.59	3.18	3.18	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	96.61	5.33	1.33	1.33	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	138.04	8.66	4.08	5.60	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	122.20	9.34	6.40	2.93	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	141.14	7.18	6.05	3.59	1.51
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	128.23	7.36	6.14	4.29	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	123.94	6.52	9.79	1.63	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	132.44	9.79	4.58	5.00	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	125.56	8.69	5.32	4.20	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	117.46	9.27	6.18	10.30	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	137.02	7.55	3.77	3.77	1.74
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	118.08	10.16	3.29	2.09	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	120.06	4.43	3.87	2.77	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	143.87	9.19	6.36	3.53	2.12
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	145.67	8.48	6.64	2.95	1.84
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	99.01	4.61	6.91	3.45	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	151.97	7.29	6.14	4.61	2.30
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	151.16	11.32	3.96	4.53	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	127.17	5.74	7.38	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	155.45	8.13	5.87	1.81	2.71
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	141.47	9.34	2.87	2.87	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	134.44	5.23	7.47	3.73	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	182.45	8.55	6.69	6.32	2.23
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	136.12	6.03	5.17	2.15	1.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	124.16	6.85	5.14	2.57	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	153.59	10.00	4.00	4.33	2.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	159.88	9.65	10.86	4.22	3.02
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	134.38	5.69	4.98	7.82	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	145.74	8.94	5.16	3.09	2.41
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	136.87	11.81	6.98	6.44	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	117.16	5.39	5.39	1.35	2.02
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	157.05	12.96	7.04	4.82	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	169.79	5.81	3.49	1.16	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	105.77	8.46	5.29	4.23	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	145.65	13.61	4.00	5.60	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	162.82	14.54	6.54	3.63	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	165.57	9.96	8.43	4.60	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	156.37	8.39	7.89	5.92	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	107.27	14.11	3.76	3.76	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	156.88	10.06	4.02	5.03	3.02
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	150.51	6.76	6.31	3.15	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	175.55	8.61	6.88	5.16	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	156.32	9.35	5.34	8.46	2.67
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	154.06	11.34	7.82	4.30	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	147.12	7.26	8.58	4.62	2.64
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	139.59	8.82	4.15	3.11	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	164.53	9.63	6.13	4.81	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	121.32	5.03	5.59	0.56	2.24
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	149.72	10.16	8.83	2.21	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	154.29	6.94	11.19	2.31	1.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	122.54	5.06	6.08	4.05	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	132.17	4.33	8.17	3.36	1.92
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	147.89	7.55	10.34	5.17	1.59
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	125.17	7.29	4.25	3.04	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	116.90	5.53	4.15	2.08	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	139.46	10.64	6.46	3.80	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	126.52	2.58	4.13	5.16	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	126.98	5.44	6.05	3.02	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	135.63	9.51	5.70	2.54	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	123.14	9.06	5.33	4.26	3.20
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	136.77	6.90	6.32	6.90	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	137.81	10.28	4.11	4.11	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	142.89	6.37	2.83	4.24	2.12
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	140.17	7.38	8.51	3.40	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	137.29	11.23	3.33	4.16	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	156.61	14.09	4.70	4.70	2.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	126.10	6.26	6.68	6.26	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	164.02	12.08	4.65	6.04	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	127.12	11.37	2.01	2.68	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	146.49	7.48	6.42	4.81	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	162.45	9.70	7.27	4.45	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	145.92	6.42	4.59	3.67	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	152.04	8.00	4.45	7.11	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	157.28	8.55	4.56	3.99	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	142.64	9.20	8.44	7.67	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	143.36	8.75	4.92	4.92	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	147.00	9.80	3.12	2.23	3.12
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	176.77	13.78	7.54	6.76	3.12
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	153.18	9.95	4.64	5.97	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	185.00	12.47	4.16	2.08	2.08
Macrophage - monocyte derived, donor1	11232-116C8	73.16	4.33	4.56	3.42	1.14
Macrophage - monocyte derived, donor2	11313-117C8	65.51	2.94	5.51	2.75	2.02
Macrophage - monocyte derived, donor3	11389-118C3	69.74	5.11	4.46	3.54	2.62
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	67.97	20.71	2.12	0.53	0.53
Mallassez-derived cells, donor2	11929-125I3	177.15	35.49	10.77	4.75	2.38
Mallassez-derived cells, donor3	11930-125I4	116.47	38.36	6.25	5.56	1.25
Mammary Epithelial Cell, donor1	11273-116H4	126.65	39.06	5.18	7.07	2.69
Mammary Epithelial Cell, donor2	11350-117G9	147.96	43.43	6.37	6.95	2.61
Mammary Epithelial Cell, donor3	11422-118F9	161.38	44.40	9.73	10.48	2.49
Mast cell - stimulated, donor1	11487-119E2	57.62	3.39	3.39	1.36	0.68
Mast cell, donor1	11563-120D6	109.65	7.89	7.35	1.73	3.03
Mast cell, donor2	11565-120D8	125.11	8.92	13.67	1.19	1.49
Mast cell, donor3	11566-120D9	157.14	9.00	14.63	5.85	0.90
Mast cell, donor4	11567-120E1	127.12	6.38	10.64	4.61	1.24
Mast cell, expanded and stimulated, donor5	11940-126A5	130.08	15.08	12.86	3.55	3.66
Mast cell, expanded and stimulated, donor8	11942-126A7	78.21	29.18	3.50	2.33	3.50
Mast cell, expanded, donor5	11939-126A4	152.92	15.03	18.01	3.10	4.24
Mast cell, expanded, donor8	11941-126A6	126.70	13.56	12.39	2.51	4.52
Melanocyte - dark, donor1	11502-119F8	89.05	19.40	2.98	4.08	0.90
Melanocyte - dark, donor2	11582-120F7	92.75	16.61	3.46	1.38	1.04
Melanocyte - dark, donor3	11663-122F7	103.59	26.44	4.13	6.23	2.32
Melanocyte - light, donor1	11274-116H5	126.23	20.92	4.47	4.23	2.82
Melanocyte - light, donor2	11351-117H1	181.54	32.08	9.55	6.14	3.41
Melanocyte - light, donor3	11423-118G1	104.07	22.55	4.34	3.47	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	58.21	17.08	3.33	5.62	0.73
Melanocyte, donor2 (MC+2)	12739-135I3	70.19	15.33	2.15	3.23	2.15
Melanocyte, donor3 (MC+3)	12837-137B2	79.82	14.73	4.29	3.21	0.54
Meningeal Cells, donor1	11493-119E8	220.70	33.74	10.30	9.80	4.09
Meningeal Cells, donor2	11573-120E7	117.52	11.00	7.92	6.60	0.00
Meningeal Cells, donor3	11654-122E7	160.72	43.28	8.15	7.74	1.96
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	159.12	18.82	9.41	3.71	1.14
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	66.01	11.47	3.02	2.11	2.31
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	111.70	11.83	6.57	3.94	11.83
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	170.06	32.70	6.54	6.54	2.62
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	76.07	19.38	3.59	5.02	2.87
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	109.70	9.53	4.02	1.27	2.54
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	125.16	6.03	6.53	3.02	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	163.50	34.72	6.59	5.05	2.20
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	188.49	29.95	12.42	5.11	2.19
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	129.51	36.62	7.57	6.75	2.86
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	92.25	9.97	4.85	4.29	3.60
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	216.72	16.36	4.83	5.20	1.86
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	121.18	11.97	4.47	5.26	2.24
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	104.45	5.64	2.67	1.19	2.97
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	84.08	7.01	2.34	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	128.08	36.50	5.12	8.97	3.84
Mesenchymal stem cells - adipose, donor0	11217-116B2	131.85	30.13	9.22	4.96	2.48
Mesenchymal stem cells - hepatic, donor0	11218-116B3	113.52	10.32	1.56	3.75	1.88
Mesenchymal stem cells - umbilical, donor0	11214-116A8	82.73	33.38	2.18	3.63	5.08
Mesothelial Cells, donor1	11247-116E5	129.14	10.87	6.89	2.39	1.86
Mesothelial Cells, donor2	12156-128G5	105.60	6.01	3.50	2.50	1.00
Mesothelial Cells, donor3	11402-118D7	91.13	7.01	7.08	1.30	1.30
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	74.27	1.35	12.15	2.70	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	77.33	3.45	5.91	1.97	1.72
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	61.84	2.06	5.30	1.77	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	65.68	6.91	10.37	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	57.65	3.10	5.27	3.41	0.93
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	45.01	2.49	3.53	4.77	1.66
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	46.32	2.32	6.95	4.63	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	66.57	3.50	6.01	5.26	2.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	59.58	2.33	7.45	0.93	1.40
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	194.66	19.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	57.71	3.86	3.86	1.42	1.02
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	60.98	5.15	5.94	1.98	1.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	59.86	0.00	17.10	8.55	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	64.60	2.65	0.88	4.42	3.54
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	54.71	3.04	6.84	2.28	3.04
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	57.90	2.63	5.26	2.63	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	59.85	3.40	2.97	1.06	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	38.67	2.76	1.84	0.92	1.84
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	56.93	2.38	5.37	1.19	1.19
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	70.42	1.68	5.03	1.68	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	101.85	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	54.70	2.01	2.26	3.26	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	47.30	3.09	4.75	2.61	1.19
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	57.50	2.21	4.98	2.21	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	67.23	3.22	2.76	0.92	0.92
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	46.48	4.63	6.31	3.37	1.68
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	48.92	3.67	3.67	2.45	1.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	53.85	2.79	3.65	1.72	0.64
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	49.13	1.78	4.67	1.33	0.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	113.50	0.00	10.32	0.00	10.32
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	53.44	1.97	2.63	1.31	0.88
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	39.04	5.07	5.58	1.52	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	72.91	4.97	3.31	0.00	3.31
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	61.42	1.90	2.72	1.09	0.82
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	56.17	2.65	8.23	2.65	0.88
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	67.60	4.36	3.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	60.55	3.84	3.36	2.40	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	67.64	5.20	8.81	2.80	1.20
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	79.53	0.00	8.23	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	79.09	4.00	6.51	2.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	107.79	0.00	26.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	63.19	0.00	2.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	82.77	4.38	4.38	0.44	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	62.91	1.10	6.62	1.10	2.21
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	78.77	3.20	5.76	1.28	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	75.62	3.72	2.48	1.74	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	57.76	0.70	5.57	0.70	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	132.59	4.42	6.63	0.00	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	90.60	1.71	4.79	3.08	2.05
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	76.14	3.06	7.00	1.75	1.31
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	136.36	3.91	8.52	1.07	1.07
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	99.60	5.89	3.37	1.12	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	59.02	4.16	4.57	1.25	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	75.76	5.83	2.91	0.58	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	95.63	5.73	5.43	1.51	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	72.63	4.59	5.84	2.50	2.50
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	115.50	14.44	14.44	7.22	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	89.58	8.31	6.46	1.85	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	75.69	3.98	7.40	0.57	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	80.84	3.59	5.25	0.55	0.69
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	76.71	6.74	3.89	1.81	0.78
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	81.51	3.86	5.15	2.57	2.57
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	85.75	3.81	4.45	1.91	1.27
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	87.01	6.41	5.07	0.27	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	77.53	4.79	3.89	2.99	1.80
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	60.60	3.67	3.96	1.27	0.42
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	86.00	6.69	3.50	0.96	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	83.37	4.42	8.40	1.99	1.55
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	80.01	6.07	6.07	1.90	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	76.42	4.83	5.40	0.85	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	78.41	5.41	6.88	1.23	1.23
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	87.32	5.21	4.56	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	78.80	2.06	2.94	0.59	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	73.23	4.04	5.19	1.15	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	82.43	2.47	7.83	2.06	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	77.72	2.98	2.98	1.79	1.19
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	33.90	3.77	3.77	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	37.43	0.00	1.78	0.00	3.56
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	52.57	7.23	4.60	3.94	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	66.27	4.21	4.21	3.16	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	47.84	4.15	5.34	3.16	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	40.05	1.86	3.73	1.86	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	38.68	4.88	1.88	2.25	1.50
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	47.94	2.40	4.53	1.60	1.07
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	75.89	3.85	2.94	2.04	1.02
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	38.31	5.16	2.21	2.21	2.21
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	43.24	4.76	2.20	4.03	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	48.22	1.56	3.11	1.56	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	18.71	0.53	1.60	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	50.23	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	40.40	5.05	4.04	4.04	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	18.13	0.84	2.11	1.26	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	24.51	0.00	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	7.63	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	9.72	0.00	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	12.08	1.51	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	211.28	0.00	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	110.92	6.52	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	66.53	4.75	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	104.27	17.02	4.96	4.09	2.15
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	70.03	4.70	4.18	2.09	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	21.36	3.34	4.00	4.67	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	27.13	8.35	4.17	1.25	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	103.06	17.87	4.37	3.23	1.14
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	172.35	14.36	20.75	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	22.44	8.84	2.72	1.36	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	95.56	12.86	5.51	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	26.79	6.70	1.26	3.35	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	49.97	13.25	5.58	2.79	3.02
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	25.40	7.30	3.24	2.16	1.35
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	79.68	5.89	5.26	0.84	2.10
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	200.42	22.27	0.00	0.00	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	38.72	7.45	5.96	2.98	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	63.61	7.58	5.68	0.81	2.98
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	23.35	7.25	3.63	1.13	1.59
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	24.01	4.08	2.78	2.29	1.80
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	64.88	6.20	4.37	1.64	1.09
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	35.54	4.77	5.30	1.06	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	15.01	3.60	1.80	0.60	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	93.53	5.91	5.91	2.30	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	17.40	4.55	2.60	2.28	0.98
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	69.14	4.76	5.29	1.06	0.88
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	23.21	2.81	2.11	0.70	2.11
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	45.05	5.52	3.68	2.76	1.84
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	18.32	7.07	3.53	1.61	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	78.98	5.86	4.48	1.38	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	146.65	7.59	7.59	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	62.16	3.56	4.90	1.11	1.11
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	35.56	5.50	4.23	0.42	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	51.03	5.22	1.90	1.90	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	20.60	6.44	2.58	2.15	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	144.44	18.06	0.00	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	26.32	5.00	1.33	2.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	57.71	4.06	4.06	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	22.22	5.16	0.79	1.98	1.59
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	24.14	4.64	1.86	2.79	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	43.89	7.57	4.92	1.51	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	23.14	3.58	1.30	0.65	2.28
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	24.40	2.61	1.74	1.74	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	58.34	2.26	4.98	0.90	1.81
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	21.17	8.82	0.88	3.53	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	17.29	3.99	1.99	0.66	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	23.81	9.92	1.49	2.98	1.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	16.84	3.45	1.53	1.53	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	86.20	12.10	4.23	7.26	4.84
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	69.40	6.19	3.76	1.55	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	22.36	4.07	2.03	5.42	1.36
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	112.41	0.00	10.22	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	20.73	5.49	1.22	3.05	1.83
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	34.31	1.89	2.52	1.57	2.20
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	20.28	6.66	2.42	3.33	1.82
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	16.61	7.91	2.37	0.00	2.37
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	115.63	10.20	4.53	1.13	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	96.10	5.06	10.12	0.00	5.06
Myoblast, donor1	11241-116D8	133.42	28.20	7.83	2.11	3.23
Myoblast, donor2	11322-117D8	87.26	17.64	5.75	3.26	3.07
Myoblast, donor3	11398-118D3	120.40	17.32	8.24	3.70	1.68
NK T cell leukemia cell line:KHYG-1	10777-110G3	69.46	36.19	4.96	6.86	3.21
Natural Killer Cells, donor1	11230-116C6	67.65	14.15	4.00	2.77	2.77
Natural Killer Cells, donor2	11311-117C6	49.76	14.78	4.52	1.21	3.02
Natural Killer Cells, donor3	11387-118C1	59.63	10.12	5.34	2.76	3.68
Neural stem cells, donor1	11275-116H6	147.35	15.24	5.81	6.17	1.09
Neural stem cells, donor2	11352-117H2	273.44	17.33	1.93	9.63	3.85
Neurons, donor1	11494-119E9	128.58	5.69	3.41	2.28	1.14
Neurons, donor2	11574-120E8	218.40	11.89	7.05	5.94	1.76
Neurons, donor3	11655-122E8	70.71	2.47	4.11	3.29	0.00
Neutrophils, donor1	11233-116C9	148.48	0.00	13.92	0.00	0.00
Neutrophils, donor2	11314-117C9	130.45	0.00	8.70	0.00	0.00
Neutrophils, donor3	11390-118C4	235.17	0.61	18.33	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	104.72	9.14	5.22	3.68	2.26
Nucleus Pulposus Cell, donor2	11409-118E5	61.54	6.84	3.26	2.60	1.95
Nucleus Pulposus Cell, donor3	11462-119B4	70.59	5.21	4.41	3.21	2.01
Olfactory epithelial cells, donor1	11933-125I7	36.75	5.09	3.72	1.38	0.96
Olfactory epithelial cells, donor2	11934-125I8	65.71	7.24	5.07	2.46	1.16
Olfactory epithelial cells, donor3	11935-125I9	41.32	8.17	3.97	2.50	0.79
Olfactory epithelial cells, donor4	11936-126A1	70.13	7.79	4.48	3.60	1.75
Oligodendrocyte - precursors, donor1	11496-119F2	161.89	17.45	5.42	2.41	1.20
Osteoblast - differentiated, donor1	11276-116H7	123.79	12.97	5.53	3.19	2.77
Osteoblast - differentiated, donor2	11353-117H3	50.30	3.43	3.43	4.57	1.14
Osteoblast - differentiated, donor3	11425-118G3	37.86	3.72	1.24	1.86	0.62
Osteoblast, donor1	11277-116H8	214.98	25.60	8.21	6.84	2.74
Osteoblast, donor2	11354-117H4	135.55	19.66	5.62	6.32	0.70
Osteoblast, donor3	11426-118G4	163.33	20.26	6.40	4.44	3.02
Pancreatic stromal cells, donor1	11249-116E7	109.25	13.48	5.22	4.89	1.94
Pericytes, donor1	11491-119E6	162.34	12.24	7.68	5.56	2.56
Pericytes, donor2	11571-120E5	120.65	9.28	8.60	2.94	2.49
Pericytes, donor3	11652-122E5	123.49	23.40	6.92	5.09	3.46
Perineurial Cells, donor1	11499-119F5	163.99	23.96	5.65	5.99	1.70
Perineurial Cells, donor2	11579-120F4	128.54	19.78	3.96	3.13	1.56
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	115.06	6.06	6.37	2.55	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	63.42	5.39	4.16	0.98	1.47
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	63.54	5.69	5.18	1.55	1.55
Placental Epithelial Cells, donor1	11278-116H9	123.89	12.68	5.02	4.07	1.43
Placental Epithelial Cells, donor2	11355-117H5	108.67	28.83	0.00	1.11	1.11
Placental Epithelial Cells, donor3	11427-118G5	90.31	14.14	4.12	2.94	1.18
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	52.53	7.59	2.22	1.90	1.90
Preadipocyte - breast, donor1	11467-119B9	119.68	16.32	5.06	1.13	1.88
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	248.26	38.38	12.40	7.05	5.61
Preadipocyte - breast, donor2	11328-117E5	96.81	11.26	4.05	3.83	2.70
Preadipocyte - omental, donor1	11468-119C1	137.57	11.83	6.07	2.34	3.30
Preadipocyte - omental, donor2	11329-117E6	123.96	9.17	4.80	1.31	3.49
Preadipocyte - omental, donor3	11403-118D8	76.92	19.77	5.16	2.58	1.29
Preadipocyte - perirenal, donor1	11469-119C2	106.30	6.89	0.00	1.97	1.97
Preadipocyte - subcutaneous, donor1	11279-116I1	238.63	35.93	9.83	7.37	2.46
Preadipocyte - subcutaneous, donor2	11356-117H6	111.20	22.13	6.73	5.49	1.24
Preadipocyte - subcutaneous, donor3	11428-118G6	81.06	14.64	4.60	3.58	2.72
Preadipocyte - visceral, donor1	11280-116I2	117.65	30.46	4.56	6.33	3.26
Preadipocyte - visceral, donor2	11357-117H7	104.00	16.57	4.60	5.52	0.92
Preadipocyte - visceral, donor3	11429-118G7	62.38	11.60	5.12	3.87	1.57
Prostate Epithelial Cells (polarized), donor1	11253-116F2	106.35	13.73	1.81	4.07	0.91
Prostate Epithelial Cells, donor2	11331-117E8	91.40	19.50	3.52	3.25	2.17
Prostate Epithelial Cells, donor3	11404-118D9	62.03	5.70	2.51	1.96	1.22
Prostate Stromal Cells, donor1	11254-116F3	112.31	19.70	5.58	3.19	2.51
Prostate Stromal Cells, donor2	11332-117E9	88.57	16.85	4.12	3.05	0.72
Prostate Stromal Cells, donor3	11405-118E1	74.87	7.61	5.74	1.67	1.25
Renal Cortical Epithelial Cells, donor1	11516-119H4	208.04	29.20	4.38	5.84	1.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	140.15	25.23	4.57	5.48	1.52
Renal Epithelial Cells, donor1	11517-119H5	231.30	48.69	10.14	5.07	2.03
Renal Epithelial Cells, donor2	11597-120H4	144.40	38.41	2.13	6.40	0.00
Renal Epithelial Cells, donor3	11678-122H4	154.67	24.98	7.20	4.34	1.16
Renal Glomerular Endothelial Cells, donor1	11514-119H2	119.83	14.98	4.77	3.40	4.09
Renal Glomerular Endothelial Cells, donor2	11594-120H1	146.76	23.31	9.57	3.64	2.29
Renal Glomerular Endothelial Cells, donor3	11675-122H1	128.54	24.42	5.77	2.00	1.11
Renal Glomerular Endothelial Cells, donor4	11783-124B1	77.86	21.29	3.99	5.32	0.67
Renal Mesangial Cells, donor1	11518-119H6	303.50	27.51	10.56	6.60	3.08
Renal Mesangial Cells, donor2	11598-120H5	198.13	30.72	11.29	5.64	2.51
Renal Mesangial Cells, donor3	11679-122H5	199.46	18.86	13.87	3.88	3.33
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	236.21	42.68	9.13	8.59	2.68
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	153.07	26.99	11.39	3.37	1.69
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	198.25	27.58	11.19	10.22	0.96
Retinal Pigment Epithelial Cells, donor0	11215-116A9	179.94	18.15	7.52	8.30	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	162.30	15.35	5.97	5.97	1.42
Retinal Pigment Epithelial Cells, donor2	11608-120I6	193.48	16.47	7.20	4.12	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	109.14	7.53	4.01	3.26	1.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	100.90	7.08	6.01	2.41	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	127.76	22.34	5.36	7.15	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	144.20	35.22	2.75	8.26	2.75
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	139.21	17.40	4.06	3.48	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	192.83	23.40	8.45	7.02	1.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	147.47	28.90	8.44	8.34	2.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	212.04	39.60	8.48	8.59	2.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	186.06	32.13	9.55	11.16	2.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	155.00	35.31	6.76	11.89	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	191.15	33.05	7.40	9.71	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	156.21	28.07	6.16	6.57	2.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	155.51	35.40	9.53	7.26	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	199.62	38.17	7.53	7.53	2.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	161.39	29.70	7.17	9.32	1.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	141.23	32.52	8.05	8.16	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	166.62	31.64	9.29	8.63	2.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	151.03	20.84	7.07	4.97	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	142.63	29.91	8.85	9.41	1.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	230.19	43.97	8.27	11.84	2.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	154.21	22.96	7.83	6.10	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	146.60	26.96	9.93	7.69	1.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	172.82	29.03	10.31	10.31	1.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	149.72	22.75	8.01	5.87	2.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	156.13	32.52	9.53	7.57	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	171.24	30.25	8.89	5.81	3.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	158.63	20.42	10.39	6.20	2.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	145.07	25.75	7.85	8.34	2.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	171.80	33.71	9.54	8.33	2.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	169.83	33.49	9.67	9.67	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	143.85	34.33	9.72	8.73	2.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	187.31	37.42	7.95	10.06	2.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	150.33	27.79	8.71	8.50	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	160.60	31.41	6.42	8.18	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	160.42	29.03	10.44	10.44	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	162.85	27.32	7.81	6.59	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	152.75	24.86	9.03	4.94	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	163.68	34.32	8.29	6.17	1.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	161.97	30.26	8.42	7.22	2.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	141.70	24.42	9.05	6.31	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	165.98	29.55	9.19	5.25	1.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	149.47	23.52	9.88	5.97	2.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	160.09	23.53	6.81	4.44	2.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	152.73	21.32	9.86	5.60	3.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	130.25	22.12	4.29	7.19	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	134.53	28.57	8.81	5.71	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	171.11	25.60	8.46	5.84	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	127.89	24.01	6.40	6.97	1.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	145.68	22.36	6.64	6.64	2.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	103.36	13.30	7.86	4.84	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	136.22	30.60	6.00	8.08	2.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	231.72	23.43	9.32	5.39	2.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	170.36	33.46	5.48	5.48	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	122.97	26.22	5.43	4.82	2.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	163.76	25.56	6.79	7.01	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	173.13	31.15	5.69	5.99	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	184.43	22.67	6.49	5.67	3.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	149.84	24.33	6.83	6.62	1.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	162.26	30.05	4.81	4.21	3.61
Schwann Cells, donor1	11498-119F4	161.18	28.59	9.40	7.33	2.82
Schwann Cells, donor2	11578-120F3	51.04	23.82	0.00	6.80	0.00
Schwann Cells, donor3	11659-122F3	124.44	20.81	5.70	6.13	2.85
Sebocyte, donor1	11220-116B5	197.20	45.46	12.05	6.57	1.10
Sebocyte, donor2	11301-117B5	94.67	26.19	0.92	5.51	0.00
Sebocyte, donor3	11378-118B1	80.80	9.89	3.71	2.06	1.86
Sertoli Cells, donor1	11255-116F4	139.15	16.57	1.66	1.66	1.66
Sertoli Cells, donor2	11333-117F1	84.73	16.95	2.82	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	150.88	14.43	6.33	5.19	2.82
Skeletal Muscle Cells, donor2	11358-117H8	83.13	2.89	5.78	5.06	0.72
Skeletal Muscle Cells, donor3	11430-118G8	202.32	51.83	17.56	18.39	3.34
Skeletal Muscle Cells, donor4	11451-119A2	111.38	24.51	6.13	7.23	1.73
Skeletal Muscle Cells, donor5	11455-119A6	97.66	25.27	6.09	10.55	2.82
Skeletal Muscle Cells, donor6	11459-119B1	85.57	31.09	5.08	8.93	1.54
Skeletal Muscle Satellite Cells, donor1	11240-116D7	134.95	23.44	6.43	6.80	3.53
Skeletal Muscle Satellite Cells, donor2	11321-117D7	137.41	25.83	8.42	5.85	2.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	120.44	31.55	8.33	6.35	2.38
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	142.81	14.32	6.57	4.97	2.78
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	167.19	42.70	7.24	12.30	1.45
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	117.78	13.35	9.63	3.44	2.20
Skin - palm, donor1	10286-104F7	48.35	0.00	5.37	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	54.78	25.37	2.59	1.59	1.44
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	184.84	34.35	4.91	2.45	4.09
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	54.40	22.07	2.08	2.99	1.69
Small Airway Epithelial Cells, donor1	11256-116F5	125.11	23.77	5.70	2.22	2.22
Small Airway Epithelial Cells, donor2	11334-117F2	74.27	15.19	3.24	1.27	1.13
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	145.90	31.08	5.29	5.71	2.75
Small Airway Epithelial Cells, donor3	11406-118E2	63.71	9.67	4.42	1.80	0.52
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	59.56	11.11	3.09	2.78	2.47
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	140.51	24.90	6.45	4.00	3.56
Smooth Muscle Cells - Aortic, donor0	11210-116A4	155.77	22.93	12.34	6.47	4.11
Smooth Muscle Cells - Aortic, donor1	11283-116I5	124.64	14.81	7.51	5.52	3.09
Smooth Muscle Cells - Aortic, donor2	11360-117I1	207.52	24.02	9.84	4.73	1.58
Smooth Muscle Cells - Aortic, donor3	11432-118H1	154.51	30.13	11.59	3.09	2.32
Smooth Muscle Cells - Bladder, donor1	11519-119H7	64.05	5.00	0.00	4.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	184.18	27.41	7.45	5.99	2.79
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	68.49	12.86	4.65	0.66	3.10
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	86.68	10.75	7.04	2.18	2.43
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	126.65	14.00	8.47	4.23	2.60
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	117.54	12.99	4.73	4.43	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	85.13	12.24	4.13	1.85	1.71
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	177.97	23.91	6.02	8.46	2.11
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	102.59	3.96	5.48	1.52	1.52
Smooth Muscle Cells - Carotid, donor1	11285-116I7	211.90	20.46	9.34	7.07	2.02
Smooth Muscle Cells - Carotid, donor2	11362-117I3	153.02	6.12	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	104.90	12.87	6.68	4.77	1.91
Smooth Muscle Cells - Colonic, donor1	11239-116D6	102.35	13.72	4.13	2.36	1.62
Smooth Muscle Cells - Colonic, donor2	11320-117D6	112.57	19.16	4.09	2.37	2.80
Smooth Muscle Cells - Colonic, donor3	11396-118D1	109.89	20.26	6.30	5.46	2.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	202.17	23.67	10.98	4.49	2.94
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	183.24	36.65	5.39	8.62	6.47
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	122.23	20.02	7.77	2.69	2.69
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	204.50	28.34	6.83	8.88	3.07
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	101.15	11.86	3.85	5.34	2.12
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	161.43	23.75	10.67	3.72	3.42
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	93.07	9.10	3.41	3.19	1.59
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	151.56	21.74	8.45	7.25	5.43
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	136.17	43.98	6.89	8.74	1.59
Smooth Muscle Cells - Prostate, donor1	11257-116F6	114.78	11.72	4.39	4.26	2.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	90.16	10.89	4.26	3.26	2.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	60.88	5.83	3.04	2.28	2.28
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	194.20	27.44	12.66	5.58	1.66
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	165.79	12.00	6.75	6.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	125.34	16.80	14.21	15.51	5.17
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	260.44	31.62	11.63	7.44	4.19
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	90.88	23.22	4.54	2.02	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	98.41	15.98	6.27	2.19	1.88
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	104.72	23.60	5.90	5.60	3.83
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	90.47	18.24	3.50	4.50	1.42
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	63.53	6.07	2.34	3.27	1.40
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	157.88	23.03	8.06	4.61	2.30
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	164.19	19.38	11.73	4.33	1.78
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	109.44	17.68	7.52	5.64	3.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	131.50	26.13	6.57	4.61	1.40
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	114.45	14.41	4.94	3.35	1.84
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	60.00	9.05	2.86	2.38	3.81
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	130.16	18.35	5.87	3.18	2.69
Smooth Muscle Cells - Uterine, donor1	11258-116F7	114.89	8.62	8.62	2.87	1.77
Smooth Muscle Cells - Uterine, donor3	11466-119B8	149.80	15.80	9.95	6.44	2.34
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	61.22	5.25	2.53	1.94	1.55
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	63.47	8.99	5.02	2.91	1.59
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	83.69	11.16	2.98	3.72	2.98
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	98.82	12.22	1.80	2.52	2.16
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	94.25	13.34	3.12	2.84	1.99
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	105.95	16.15	3.94	3.94	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	75.42	8.13	2.03	3.05	1.78
Smooth muscle cells - airway, control, donor2	11967-126D5	57.10	6.39	0.80	5.99	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	63.12	9.61	1.25	3.34	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	64.63	7.79	1.83	1.83	2.75
Synoviocyte, donor1	11291-117A4	124.73	11.28	5.05	5.05	1.35
Synoviocyte, donor2	11368-117I9	53.30	3.69	3.52	1.17	1.01
Synoviocyte, donor3	11440-118H9	45.58	3.57	4.24	0.89	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	280.86	50.74	7.86	11.43	4.29
Trabecular Meshwork Cells, donor2	11612-122A1	152.62	27.75	11.89	5.95	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	175.98	29.41	9.49	5.56	2.78
Tracheal Epithelial Cells, donor1	11292-117A5	101.79	27.31	3.37	3.37	0.93
Tracheal Epithelial Cells, donor2	11369-118A1	119.06	40.59	6.96	6.96	1.16
Tracheal Epithelial Cells, donor3	11441-118I1	92.20	32.07	6.87	4.01	2.86
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	102.36	5.54	6.27	3.57	0.86
Urethra, donor2	10319-105A4	88.12	3.60	1.80	1.80	1.80
Urothelial Cells, donor1	11520-119H8	189.42	28.43	12.75	3.19	2.39
Urothelial Cells, donor2	11600-120H7	101.34	21.23	5.21	3.20	1.20
Urothelial Cells, donor3	11681-122H7	125.15	20.63	7.11	4.35	1.38
Urothelial cells, donor0	11216-116B1	163.83	23.18	9.36	2.23	3.57
Whole blood (ribopure), donor090309, donation1	12179-129A1	168.17	4.45	23.13	3.56	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	195.86	2.86	12.87	1.43	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	137.59	5.48	15.74	1.37	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	114.32	8.95	8.95	4.48	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	126.66	12.20	9.30	2.32	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	213.45	10.41	18.74	1.04	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	192.74	5.51	11.93	3.67	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	119.59	6.39	16.43	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	113.49	20.72	4.19	4.69	0.86
Wilms' tumor cell line:HFWT	10597-108E3	87.12	5.28	4.40	5.28	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	61.73	26.26	2.51	7.26	0.56
achilles tendon, donor2	10292-104G4	28.93	4.13	4.13	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	64.50	116.51	2.04	5.86	3.57
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	80.33	59.44	2.09	9.52	3.71
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	162.39	57.22	3.44	6.29	8.07
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	96.33	90.89	2.45	9.80	6.53
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	51.72	141.67	2.25	8.43	5.06
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	62.18	20.30	2.96	5.92	2.54
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	79.21	25.59	6.26	2.18	2.99
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	59.05	80.64	3.97	10.13	3.97
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	71.05	49.00	2.04	7.35	4.90
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	74.94	80.38	6.99	8.93	9.71
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	35.70	60.17	1.47	8.83	3.86
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	27.30	11.70	11.70	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	83.89	54.14	2.79	7.20	2.32
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	83.11	70.16	5.70	11.91	3.37
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	72.77	64.88	4.38	13.15	2.92
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	103.64	24.17	7.90	5.11	2.32
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	62.51	30.02	2.06	2.47	3.29
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	56.17	25.17	2.76	7.37	2.76
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	87.90	50.78	5.12	8.53	2.13
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	95.23	36.70	8.19	11.22	5.46
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	88.58	45.01	5.78	10.59	3.61
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	81.75	81.08	5.12	12.47	5.79
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	53.70	29.02	2.33	7.34	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	87.34	14.87	5.57	5.57	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	61.40	29.76	1.13	7.16	1.88
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	64.98	37.07	1.74	4.80	6.98
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	76.85	26.24	11.25	0.00	3.75
adenocarcinoma cell line:IM95m	10796-110I4	50.63	17.90	4.24	9.42	2.12
adipose tissue, adult, pool1	10010-101C1	116.03	5.74	5.74	4.81	0.78
adipose, donor1	10184-103D4	411.07	8.21	12.90	2.93	0.00
adipose, donor2	10185-103D5	104.22	3.24	6.08	2.84	0.41
adipose, donor3	10186-103D6	122.80	6.81	7.08	6.53	0.00
adipose, donor4	10187-103D7	102.28	35.54	3.47	16.47	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	95.01	29.04	5.21	16.10	5.68
adrenal gland, adult, pool1	10081-102A9	61.84	14.55	7.28	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	75.37	49.49	4.00	6.80	3.07
alveolar cell carcinoma cell line:SW 1573	10708-109H6	97.19	31.09	11.43	13.22	0.71
amniotic membrane cells, donor1	12235-129G3	103.64	15.30	6.03	4.64	1.62
amniotic membrane cells, donor2	12236-129G4	88.58	9.47	3.38	3.38	1.35
amniotic membrane cells, donor3	12237-129G5	91.92	14.14	9.43	4.12	1.77
amygdala - adult, donor10196	10167-103B5	119.77	5.93	8.30	1.19	0.00
amygdala, adult, donor10252	10151-102I7	228.32	6.69	13.59	4.46	1.01
amygdala, newborn, donor10223	10360-105E9	96.83	9.36	8.07	1.61	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	139.68	16.55	4.46	2.93	2.29
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	65.97	52.73	3.53	11.47	2.87
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	138.96	27.39	6.68	6.01	2.00
aorta, adult, pool1	10052-101G7	73.16	4.90	5.49	2.75	0.98
appendix, adult	10189-103D9	121.09	17.08	9.31	3.10	3.10
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	107.65	28.20	5.85	6.53	1.72
artery, adult	10190-103E1	118.21	5.43	2.72	2.72	0.00
astrocytoma cell line:TM-31	10425-106D2	219.04	24.05	6.23	6.52	3.48
b cell line:RPMI1788	10427-106D4	59.63	72.27	3.12	13.38	4.31
basal cell carcinoma cell line:TE 354.T	10702-109G9	144.27	14.15	6.10	3.88	2.22
bile duct carcinoma cell line:HuCCT1	10432-106D9	88.22	15.38	4.86	6.85	0.69
bile duct carcinoma cell line:TFK-1	10496-107C1	35.32	0.33	1.17	0.00	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	57.04	18.45	2.80	4.47	2.24
bladder, adult, pool1	10011-101C2	88.00	5.43	5.21	2.93	0.65
blood, adult, pool1	10053-101G8	50.94	6.64	8.86	4.43	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	91.63	5.99	5.14	2.57	0.00
bone marrow, adult	10192-103E3	105.27	13.50	7.42	7.42	2.70
brain, adult, donor1	10084-102B3	107.63	4.10	11.28	7.18	1.03
brain, adult, pool1	10012-101C3	140.65	5.23	6.68	3.79	1.78
brain, fetal, pool1	10085-102B4	187.00	13.36	8.01	2.67	2.67
breast carcinoma cell line:MCF7	10482-107A5	158.57	6.28	7.60	3.30	1.98
breast carcinoma cell line:MDA-MB-453	10419-106C5	175.75	5.12	7.86	2.62	1.00
breast, adult, donor1	10080-102A8	50.51	9.47	7.58	3.79	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	32.65	30.74	1.27	11.94	2.16
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	62.77	11.75	2.78	3.71	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	64.23	31.08	4.14	13.12	1.38
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	49.63	0.00	4.60	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	54.54	199.82	0.47	21.16	4.23
carcinoid cell line:NCI-H727	10735-110B6	111.24	8.64	3.94	3.94	1.42
carcinoid cell line:SK-PN-DW	10719-109I8	68.45	161.93	2.22	6.02	3.80
carcinosarcoma cell line:JHUCS-1	10642-109A3	193.51	42.06	9.85	13.84	2.40
caudate nucleus - adult, donor10196	10177-103C6	127.80	2.30	6.91	1.15	2.30
caudate nucleus, adult, donor10252	10164-103B2	142.73	4.18	9.70	2.68	0.33
caudate nucleus, adult, donor10258	10379-105H1	103.16	3.06	7.64	3.06	0.76
caudate nucleus, newborn, donor10223	10354-105E3	111.70	6.59	10.99	1.10	0.73
cerebellum - adult, donor10196	10173-103C2	201.02	5.83	11.65	8.74	0.00
cerebellum, adult, donor10252	10166-103B4	281.19	9.39	17.72	7.47	0.85
cerebellum, adult, pool1	10083-102B2	81.41	4.48	4.14	5.86	0.34
cerebellum, newborn, donor10223	10357-105E6	217.54	5.81	8.30	3.32	0.00
cerebral meninges, adult	10188-103D8	147.00	4.03	8.82	2.27	1.76
cerebrospinal fluid, donor2	10294-104G6	60.66	1.46	1.46	2.92	0.00
cervical cancer cell line:D98-AH2	10552-107I3	107.84	28.33	3.45	12.51	1.15
cervical cancer cell line:ME-180	10553-107I4	136.22	27.34	3.31	7.79	2.65
cervix, adult, pool1	10013-101C4	145.52	6.40	8.19	3.15	1.15
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	229.63	16.44	10.87	9.34	0.70
chondrosarcoma cell line:SW 1353	10700-109G7	134.54	5.23	14.37	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	76.93	8.58	3.85	4.35	0.87
choriocarcinoma cell line:SCH	10785-110H2	59.02	2.34	0.99	1.97	0.49
choriocarcinoma cell line:T3M-3	10618-108G6	91.55	3.08	4.74	0.71	0.00
chorionic membrane cells, donor1	12238-129G6	80.63	7.12	1.99	3.99	0.28
chorionic membrane cells, donor2	12239-129G7	129.86	10.34	4.28	3.58	1.69
chorionic membrane cells, donor3	12240-129G8	71.98	3.85	2.20	1.10	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	71.70	67.66	4.04	3.03	5.05
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	66.27	75.49	4.80	8.07	4.42
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	39.91	24.92	1.48	7.81	3.80
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	76.53	13.35	4.37	7.19	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	75.22	16.45	6.05	7.74	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	80.63	14.25	5.90	5.90	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	78.33	30.92	7.95	9.72	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	67.50	43.26	2.35	10.69	1.82
clear cell carcinoma cell line:JHOC-5	10638-108I8	107.66	30.86	9.83	11.89	1.60
clear cell carcinoma cell line:TEN	10636-108I6	107.23	11.80	3.99	4.16	1.39
colon carcinoma cell line:CACO-2	10513-107D9	84.57	20.87	2.20	5.67	1.28
colon carcinoma cell line:COLO-320	10420-106C6	144.81	196.12	6.84	28.13	6.08
colon, adult, donor1	10082-102B1	84.49	11.90	10.71	8.33	0.00
colon, adult, pool1	10014-101C5	116.68	5.76	8.58	2.59	1.18
colon, fetal, donor1	10070-101I7	67.36	3.71	8.65	0.62	1.24
common myeloid progenitor CMP, donor1	12130-128D6	252.09	27.50	4.58	4.58	4.58
common myeloid progenitor CMP, donor2	12134-128E1	75.11	25.04	0.00	25.04	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	87.54	22.95	5.10	2.97	4.67
cord blood derived cell line:COBL-a 24h infection	10453-106G3	80.30	43.02	3.62	5.89	6.19
cord blood derived cell line:COBL-a untreated	10449-106F8	80.09	39.06	3.81	4.51	4.79
corpus callosum, adult, pool1	10042-101F6	246.11	6.08	12.49	3.65	1.55
cruciate ligament, donor2	10295-104G7	65.65	0.81	3.24	2.43	0.81
diaphragm, fetal, donor1	10069-101I6	60.99	4.82	2.41	4.82	0.00
diencephalon, adult	10193-103E4	118.55	3.12	4.32	1.20	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	76.00	188.05	3.90	18.14	10.79
ductal cell carcinoma cell line:KLM-1	10438-106E6	208.23	17.44	10.77	3.08	1.80
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	194.98	44.05	7.94	6.26	2.65
ductus deferens, adult	10196-103E7	146.01	5.48	11.46	1.99	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	63.37	4.32	5.76	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	113.29	8.09	8.09	3.68	0.00
dura mater, adult, donor1	10041-101F5	134.95	5.62	6.11	2.97	1.40
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	159.23	72.84	3.78	6.00	2.66
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	196.03	100.45	6.02	19.49	2.44
embryonic pancreas cell line:1B2C6	10604-108F1	62.28	11.10	7.40	3.08	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	88.09	15.14	5.75	10.29	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	70.09	9.88	5.56	1.54	0.00
embryonic pancreas cell line:2C6	10603-108E9	103.76	13.13	2.63	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	65.03	6.70	3.02	2.35	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	190.84	16.13	12.32	7.97	2.90
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	247.65	25.41	11.42	6.59	0.64
epidermoid carcinoma cell line:A431	10426-106D3	107.05	14.78	3.89	4.00	0.44
epidermoid carcinoma cell line:Ca Ski	10431-106D8	110.98	44.10	3.74	11.66	1.32
epididymis, adult	10197-103E8	78.49	6.07	4.19	1.05	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	89.77	6.92	9.23	4.61	0.89
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	51.12	13.76	3.15	3.15	1.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	147.82	104.18	6.68	20.05	3.67
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	104.62	54.72	4.53	16.14	1.97
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	135.11	98.59	5.38	25.32	3.92
esophagus, adult, pool1	10015-101C6	119.56	8.60	6.58	4.67	1.27
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	998.38	146.65	12.90	21.42	3.88
eye - muscle inferior rectus, donor1	10272-104E2	181.09	2.41	0.00	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	79.96	6.31	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	110.13	1.49	5.95	0.00	4.46
eye - muscle superior, donor2	10297-104G9	99.75	4.59	10.32	2.29	0.00
eye - vitreous humor, donor1	10268-104D7	58.30	2.91	1.46	2.91	0.00
eye, fetal, donor1	10054-101G9	99.91	5.08	5.85	1.53	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	52.44	19.75	1.92	5.77	2.05
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	63.39	15.91	5.94	5.70	1.19
frontal lobe, adult, pool1	10040-101F4	197.31	8.35	10.79	5.82	1.97
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	194.26	8.11	8.11	1.50	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	80.28	10.15	6.22	4.48	0.46
gall bladder, adult	10198-103E9	118.06	6.76	9.66	1.93	1.69
gamma delta positive T cells, donor1	11937-126A2	85.90	17.18	6.44	4.29	2.68
gamma delta positive T cells, donor2	11938-126A3	69.84	16.06	4.11	4.48	1.87
gastric adenocarcinoma cell line:MKN1	10614-108G2	100.33	8.03	4.22	3.17	1.06
gastric adenocarcinoma cell line:MKN45	10612-108F9	100.38	7.54	4.45	6.00	0.39
gastric cancer cell line:AZ521	10549-107H9	115.92	21.48	3.44	7.38	0.98
gastric cancer cell line:GSS	10560-108A2	63.15	27.46	2.75	19.22	5.49
gastrointestinal carcinoma cell line:ECC12	10615-108G3	106.69	15.08	1.14	3.88	0.91
giant cell carcinoma cell line:LU65	10487-107B1	28.69	17.78	2.07	5.51	0.80
giant cell carcinoma cell line:Lu99B	10433-106E1	109.73	12.04	6.02	4.20	0.84
glassy cell carcinoma cell line:HOKUG	10688-109F4	91.79	6.48	8.48	2.49	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	107.87	9.29	7.49	3.48	1.37
glioblastoma cell line:A172, tech_rep2	10444-106F3	105.75	8.01	9.13	4.77	0.84
glioblastoma cell line:T98G	10485-107A8	99.23	17.33	3.97	6.07	1.32
glioma cell line:GI-1	10413-106B8	72.93	7.91	4.39	2.64	0.29
globus pallidus - adult, donor10196	10175-103C4	93.30	2.19	6.56	0.73	0.73
globus pallidus, adult, donor10252	10161-103A8	227.01	8.06	9.28	4.39	1.71
globus pallidus, adult, donor10258	10367-105F7	150.61	1.37	10.95	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	100.72	6.93	3.20	1.07	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	274.08	24.47	2.45	7.34	4.89
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	21.86	0.00	0.00	21.86
granulocyte macrophage progenitor, donor3	12139-128E6	78.40	20.91	10.45	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	112.32	9.60	6.08	3.20	0.64
hIPS +CCl2, biol_rep1	14383-156B9	195.58	60.14	3.67	10.56	2.75
hIPS +CCl2, biol_rep2	14384-156C1	238.69	54.41	2.29	9.60	0.91
hIPS +CCl2, biol_rep3	14385-156C2	221.57	53.46	3.86	8.37	0.64
hIPS, biol_rep1	14380-156B6	237.15	54.62	0.00	4.31	2.87
hIPS, biol_rep2	14381-156B7	175.58	52.81	2.06	7.54	2.06
hIPS, biol_rep3	14382-156B8	161.11	7.72	7.72	2.21	0.00
hairy cell leukemia cell line:Mo	10712-109I1	66.09	59.77	3.16	5.17	10.34
heart - mitral valve, adult	10205-103F7	103.44	3.59	6.58	1.79	0.30
heart - pulmonic valve, adult	10206-103F8	90.99	3.14	5.49	1.83	0.52
heart - tricuspid valve, adult	10207-103F9	124.06	10.82	9.16	5.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	95.50	5.31	4.90	3.88	1.02
heart, adult, diseased, donor1	10051-101G6	126.05	6.39	6.39	2.55	0.85
heart, adult, pool1	10016-101C7	112.92	5.52	5.98	2.53	0.46
heart, fetal, pool1	10046-101G1	161.72	10.06	6.98	2.36	0.72
hepatic mesenchymal tumor cell line:LI90	10778-110G4	78.98	10.80	4.94	2.47	0.93
hepatoblastoma cell line:HuH-6	10633-108I3	109.40	4.76	2.38	2.38	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	65.41	39.12	3.09	5.52	1.33
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	68.21	40.54	1.46	5.46	2.06
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	71.04	42.64	1.62	5.46	1.11
hepatoma cell line:Li-7	10484-107A7	119.78	8.56	4.00	4.23	1.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	40.10	104.62	0.90	7.34	3.02
hippocampus - adult, donor10196	10169-103B7	153.31	0.95	8.52	3.79	1.89
hippocampus, adult, donor10252	10153-102I9	231.86	5.92	13.88	3.27	0.41
hippocampus, adult, donor10258	10374-105G5	201.17	3.98	5.98	3.49	0.50
hippocampus, newborn, donor10223	10363-105F3	111.74	8.11	11.63	1.76	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	164.79	76.90	1.22	10.38	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	105.44	53.80	2.75	13.16	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	129.23	60.68	3.55	17.01	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	159.01	18.61	5.64	2.26	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	159.83	14.72	5.68	9.55	1.81
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	222.83	19.36	9.87	7.59	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	187.73	11.97	10.22	9.05	1.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	154.25	14.65	3.66	9.26	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	154.32	11.68	8.76	6.67	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	184.46	9.00	5.92	6.63	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	138.38	14.46	7.07	7.23	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	190.54	10.77	7.41	5.39	2.02
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	106.25	62.28	4.07	17.68	2.03
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	135.11	75.66	2.46	19.16	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	147.50	89.89	4.36	24.44	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	226.42	16.61	11.07	6.68	1.15
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	211.50	12.65	7.85	7.41	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	280.87	19.49	9.50	5.50	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	172.94	6.22	7.54	3.58	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	172.34	5.46	6.37	1.82	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	164.14	2.82	7.20	3.45	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	154.32	7.84	7.35	2.94	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	157.35	4.64	7.26	2.32	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	194.60	8.37	8.37	2.69	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	109.18	53.95	3.69	12.38	1.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	107.84	49.07	1.43	10.56	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	168.63	61.66	2.45	14.29	2.04
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	170.76	14.44	6.69	6.34	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	122.58	15.84	3.80	6.65	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	159.48	15.13	5.14	6.36	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	132.38	8.79	4.14	4.65	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	110.25	10.63	2.66	1.99	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	120.06	12.06	5.64	3.85	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	129.61	12.53	5.11	4.86	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	165.83	10.60	7.57	3.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	104.18	17.14	3.70	2.02	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	117.13	46.37	3.86	12.32	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	143.95	54.37	3.12	10.25	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	139.03	56.59	2.93	20.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	209.35	13.75	5.81	4.28	0.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	536.79	9.76	6.51	6.51	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	254.16	24.49	6.95	5.63	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	195.93	10.40	9.30	5.47	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	153.44	11.22	6.15	5.79	1.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	153.74	13.52	7.83	6.05	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	162.30	14.32	4.77	2.39	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	250.81	14.49	7.85	7.45	0.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	117.73	9.16	4.85	3.77	0.54
immature langerhans cells, donor1	11904-125F5	51.58	2.66	2.91	2.42	1.21
immature langerhans cells, donor2	11905-125F6	120.40	0.00	2.38	2.38	0.79
insula, adult, pool1	10039-101F3	243.78	10.60	13.34	4.92	2.27
keratoacanthoma cell line:HKA-1	10791-110H8	68.28	44.22	5.85	14.96	2.28
kidney, adult, pool1	10017-101C8	147.69	5.61	9.51	3.20	0.70
kidney, fetal, pool1	10045-101F9	214.40	7.92	8.42	4.95	1.13
large cell lung carcinoma cell line:IA-LM	10509-107D5	81.38	4.83	3.98	1.85	0.99
large cell lung carcinoma cell line:NCI-H460	10839-111E2	90.13	10.64	2.76	7.60	2.35
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	71.20	19.45	3.49	2.94	0.18
left atrium, adult, donor1	10079-102A7	44.68	2.72	3.27	2.72	0.54
left ventricle, adult, donor1	10078-102A6	56.13	3.54	5.56	2.02	0.51
leiomyoblastoma cell line:G-402	10721-110A1	131.33	73.05	6.29	10.67	2.19
leiomyoma cell line:10964C	10569-108B2	102.03	9.34	6.47	3.23	3.59
leiomyoma cell line:15242A	10570-108B3	113.59	4.89	5.98	2.72	0.54
leiomyoma cell line:15425	10571-108B4	118.49	14.33	7.77	4.86	2.19
leiomyosarcoma cell line:Hs 5.T	10722-110A2	133.34	19.05	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	107.69	18.82	12.55	2.09	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	55.02	23.38	1.65	2.95	1.42
liposarcoma cell line:KMLS-1	10782-110G8	144.03	22.81	8.59	3.12	3.44
liposarcoma cell line:SW 872	10726-110A6	104.54	15.96	4.75	3.66	2.80
liver, adult, pool1	10018-101C9	134.02	12.32	9.72	3.24	0.97
liver, fetal, pool1	10086-102B5	58.32	10.35	7.53	3.76	0.94
locus coeruleus - adult, donor10196	10182-103D2	142.62	3.50	16.04	1.31	0.73
locus coeruleus, adult, donor10252	10165-103B3	175.51	6.09	9.23	1.66	0.55
locus coeruleus, adult, donor10258	10375-105G6	86.90	3.67	6.49	2.54	3.10
locus coeruleus, newborn, donor10223	10362-105F2	120.30	11.36	6.31	3.79	0.42
lung adenocarcinoma cell line:A549	10499-107C4	61.45	3.60	2.77	3.60	1.11
lung adenocarcinoma cell line:PC-14	10408-106B3	39.99	1.38	2.76	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	37.57	3.69	2.37	2.11	0.53
lung, adult, pool1	10019-101D1	102.89	5.43	4.96	3.54	0.71
lung, fetal, donor1	10068-101I5	236.32	8.28	9.13	3.71	0.86
lung, right lower lobe, adult, donor1	10075-102A3	71.48	3.67	4.12	2.29	2.29
lymph node, adult, donor1	10077-102A5	47.34	13.73	5.68	5.21	0.47
lymphangiectasia cell line:DS-1	10727-110A7	54.14	38.36	3.29	6.36	1.97
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	164.96	63.54	10.11	3.77	5.74
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	81.55	5.10	0.85	0.00	0.85
mature adipocyte, donor1	12231-129F8	157.62	2.22	7.55	1.78	1.78
mature adipocyte, donor2	12232-129F9	136.14	4.36	5.81	2.49	0.83
mature adipocyte, donor3	12233-129G1	137.50	5.45	6.87	3.32	0.95
mature adipocyte, donor4	12234-129G2	131.08	2.63	6.05	2.90	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	156.06	16.92	17.63	10.96	3.10
medial frontal gyrus - adult, donor10196	10170-103B8	128.60	11.28	4.51	2.26	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	225.29	7.17	10.11	3.31	1.10
medial frontal gyrus, adult, donor10258	10368-105F8	109.60	6.99	7.31	3.18	1.91
medial frontal gyrus, newborn, donor10223	10352-105E1	186.80	11.09	11.94	5.54	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	150.53	6.41	12.49	3.71	1.18
medial temporal gyrus, adult, donor10252	10156-103A3	261.46	11.25	12.95	2.55	1.06
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	117.50	11.56	5.78	3.85	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	186.60	28.71	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	134.60	7.54	7.90	1.44	1.44
medulla oblongata - adult, donor10196	10174-103C3	115.52	4.54	3.24	2.60	0.00
medulla oblongata, adult, donor10252	10155-103A2	178.33	6.66	11.30	3.87	1.08
medulla oblongata, adult, pool1	10038-101F2	170.60	7.51	8.00	3.59	1.39
medulla oblongata, newborn, donor10223	10361-105F1	135.75	11.80	6.60	2.78	0.35
medulloblastoma cell line:D283 Med	10838-111E1	154.55	33.65	3.54	9.52	1.77
medulloblastoma cell line:ONS-76	10759-110E3	72.02	27.63	2.45	5.01	1.71
melanoma cell line:COLO 679	10514-107E1	98.18	7.76	7.33	3.59	1.15
melanoma cell line:G-361	10465-106H6	148.76	27.69	5.97	5.97	2.71
meningioma cell line:HKBMM	10691-109F7	78.69	11.76	5.25	3.26	1.99
merkel cell carcinoma cell line:MKL-1	10843-111E6	65.21	128.65	0.88	20.27	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	145.94	125.98	5.70	14.26	2.07
mesenchymal precursor cell - adipose, donor1	11747-123G1	131.19	27.62	7.67	4.45	3.99
mesenchymal precursor cell - adipose, donor2	11748-123G2	91.98	8.36	4.00	3.27	1.82
mesenchymal precursor cell - adipose, donor3	11749-123G3	111.81	18.63	6.63	2.90	1.24
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	76.00	9.13	3.37	3.79	1.97
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	63.16	8.09	3.66	3.27	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	106.19	11.11	6.25	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	53.04	6.01	3.09	2.06	0.86
mesenchymal precursor cell - cardiac, donor2	11753-123G7	89.02	8.05	5.41	2.65	1.50
mesenchymal precursor cell - cardiac, donor3	11754-123G8	95.10	17.64	3.58	2.79	1.33
mesenchymal precursor cell - cardiac, donor4	11755-123G9	91.02	12.42	5.40	4.59	0.95
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	131.31	13.09	8.82	1.71	1.42
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	67.19	5.60	4.61	2.63	1.98
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	117.06	11.62	8.03	3.46	1.80
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	107.87	20.25	5.24	6.28	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	98.00	13.07	4.29	2.86	2.45
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	106.40	10.42	3.95	1.44	3.95
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	74.48	4.45	5.79	1.97	1.45
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	116.28	10.94	5.70	1.60	2.74
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	145.59	10.91	5.87	3.36	2.52
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	107.00	15.09	7.77	2.69	1.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	98.65	9.98	6.48	2.89	2.01
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	86.52	5.15	5.52	1.10	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	127.34	13.45	6.87	4.86	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	176.83	26.10	10.95	1.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	98.18	11.87	2.74	3.65	1.83
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	94.64	10.74	5.63	2.05	2.81
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	95.80	13.35	5.24	1.57	2.88
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	85.65	12.02	4.62	3.70	1.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	77.90	8.24	4.24	2.82	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	91.72	10.49	4.06	3.38	2.03
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	86.45	16.11	5.11	1.57	3.54
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	89.43	10.19	4.17	3.24	2.32
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	193.21	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	96.33	15.57	5.19	3.46	3.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	89.46	11.60	3.35	4.02	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	88.21	12.02	4.33	2.64	1.92
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	71.87	8.80	3.67	0.73	2.93
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	78.88	12.75	4.36	3.69	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	83.10	13.10	3.68	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	75.60	9.45	6.01	3.01	2.58
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	123.05	2.73	8.20	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	98.13	10.33	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	101.98	17.54	5.85	2.92	1.95
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	101.85	17.46	5.82	4.36	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	88.49	14.39	5.86	2.67	2.13
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	108.76	14.72	4.91	1.64	3.27
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	84.35	9.33	4.66	4.66	3.11
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	96.54	18.89	2.10	4.20	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	98.35	13.91	5.96	1.99	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	76.28	9.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	93.69	15.42	4.15	5.93	2.96
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	110.88	14.62	4.87	1.22	3.66
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	135.26	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	108.31	14.57	6.33	3.80	3.17
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	65.53	14.49	2.41	2.07	2.76
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	66.63	6.45	2.15	4.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	55.89	15.97	0.00	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	37.88	10.33	0.00	6.89	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	50.12	7.74	2.04	1.63	2.04
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	39.72	4.77	0.79	2.38	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	48.93	9.43	1.18	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	39.90	8.10	1.56	3.12	1.25
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	56.14	16.04	6.68	4.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	53.22	10.64	2.37	2.37	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	64.20	10.27	2.57	2.57	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	72.97	15.14	4.82	4.82	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	67.29	6.93	1.98	3.96	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	62.80	3.36	0.00	2.24	2.24
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	60.43	5.72	3.82	3.18	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	61.66	0.81	5.24	2.42	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	45.79	0.00	4.36	2.18	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	72.22	3.80	2.53	5.07	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	41.88	1.21	3.64	1.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	31.63	4.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	39.54	3.29	4.12	2.47	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	49.41	5.56	2.18	2.38	0.79
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	48.35	5.19	5.19	4.22	1.30
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	68.25	9.17	4.07	1.02	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	102.13	3.09	2.32	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	115.76	7.32	15.59	4.25	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	100.78	3.48	7.18	2.09	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	64.10	8.55	0.00	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	84.26	11.30	2.88	2.57	0.51
mesothelioma cell line:Mero-25	10850-111F4	112.12	4.54	2.95	1.36	0.45
mesothelioma cell line:Mero-41	10851-111F5	105.86	21.02	6.85	5.87	2.20
mesothelioma cell line:Mero-48a	10852-111F6	99.87	13.06	7.53	1.77	0.44
mesothelioma cell line:Mero-82	10853-111F7	94.87	11.83	3.94	0.53	2.10
mesothelioma cell line:Mero-83	10854-111F8	116.43	18.38	3.40	3.40	1.87
mesothelioma cell line:Mero-84	10855-111F9	82.40	4.80	3.79	2.27	0.25
mesothelioma cell line:Mero-95	10856-111G1	67.08	7.87	3.11	2.90	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	80.84	12.42	4.31	2.65	1.16
mesothelioma cell line:NCI-H226	10846-111E9	74.75	9.59	2.35	3.62	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	100.10	10.42	8.71	6.32	2.05
mesothelioma cell line:NCI-H28	10845-111E8	82.45	5.09	8.14	4.58	0.51
mesothelioma cell line:No36	10857-111G2	77.64	10.44	3.59	5.55	0.65
mesothelioma cell line:ONE58	10858-111G3	112.17	14.09	8.13	5.42	1.35
migratory langerhans cells, donor1	11901-125F2	163.71	14.01	4.80	1.92	1.92
migratory langerhans cells, donor2	11902-125F3	142.14	14.53	7.82	2.44	1.71
migratory langerhans cells, donor3	11903-125F4	155.25	11.49	7.00	1.79	2.33
mixed mullerian tumor cell line:HTMMT	10689-109F5	100.88	13.06	2.61	2.94	1.31
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	51.50	0.85	1.48	0.21	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	79.01	6.45	2.99	3.23	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	40.72	18.84	2.66	3.81	3.43
myelodysplastic syndrome cell line:SKM-1	10772-110F7	177.03	146.91	7.02	24.21	11.64
myeloma cell line:PCM6	10474-106I6	63.65	7.91	2.37	2.57	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	103.99	11.67	3.04	3.55	2.03
myxofibrosarcoma cell line:NMFH-1	10684-109E9	100.42	12.95	6.47	6.08	0.98
nasal epithelial cells, donor1, tech_rep1	12226-129F3	74.65	7.58	3.45	2.12	0.45
nasal epithelial cells, donor1, tech_rep2	12226-129F3	72.88	8.97	3.82	2.57	1.18
nasal epithelial cells, donor2	12227-129F4	77.83	7.18	1.10	2.76	0.00
neuroblastoma cell line:CHP-134	10508-107D4	96.86	12.88	5.75	3.45	1.15
neuroblastoma cell line:NB-1	10539-107G8	150.60	28.44	8.98	10.29	2.06
neuroblastoma cell line:NBsusSR	10607-108F4	161.96	20.67	5.06	2.74	2.74
neuroblastoma cell line:NH-12	10555-107I6	101.19	27.02	1.86	8.01	1.86
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	83.98	31.31	4.98	6.41	1.66
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	102.16	28.67	2.38	5.07	1.90
neuroectodermal tumor cell line:TASK1	10774-110F9	94.99	61.18	2.62	13.89	3.02
neuroepithelioma cell line:SK-N-MC	10728-110A8	243.50	91.55	3.18	5.09	1.27
neurofibroma cell line:Hs 53.T	10729-110A9	99.28	12.51	5.32	0.80	1.33
neutrophil PMN, donor1	12133-128D9	446.24	0.00	14.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	132.81	0.00	0.00	13.28	0.00
neutrophil PMN, donor3	12141-128E8	85.24	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	181.80	35.68	5.92	6.60	3.38
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	84.85	10.41	1.60	0.80	3.20
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	79.83	6.41	2.89	3.85	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	116.67	12.09	6.83	2.63	2.10
nucleus accumbens, adult, pool1	10037-101F1	193.01	7.22	9.66	5.25	2.62
occipital cortex - adult, donor10196	10172-103C1	166.89	4.12	4.12	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	247.97	8.32	15.83	3.22	1.07
occipital cortex, newborn, donor10223	10355-105E4	146.67	6.19	13.47	1.09	1.09
occipital lobe, adult, donor1	10076-102A4	119.65	6.04	11.55	4.20	1.31
occipital lobe, fetal, donor1	10073-102A1	166.06	12.01	12.87	8.58	2.57
occipital pole, adult, pool1	10036-101E9	193.79	7.81	9.70	4.97	1.42
olfactory region, adult	10195-103E6	203.66	4.78	9.93	1.72	0.76
optic nerve, donor1	10277-104E7	146.08	0.00	4.00	2.00	4.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	62.42	19.82	2.51	4.10	0.57
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	35.86	49.18	0.69	9.34	0.96
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	44.53	6.77	2.03	2.37	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	74.39	5.54	2.43	2.31	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	115.82	7.06	6.76	2.06	2.35
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	109.32	7.47	5.61	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	118.75	32.45	3.82	5.73	1.48
ovary, adult, pool1	10020-101D2	125.79	9.00	7.25	3.23	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	124.11	45.10	5.50	9.53	6.23
pancreas, adult, donor1	10049-101G4	70.55	12.23	7.53	6.58	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	72.12	10.06	6.15	2.24	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	119.59	0.00	7.33	0.00	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	126.17	6.79	7.29	3.15	0.17
paracentral gyrus, adult, pool1	10035-101E8	193.11	10.07	9.79	3.94	2.56
parietal cortex, adult, donor10258	10373-105G4	125.52	3.67	7.34	3.67	0.73
parietal lobe - adult, donor10196	10171-103B9	148.60	3.76	8.46	0.94	0.94
parietal lobe, adult, donor10252	10157-103A4	215.20	6.84	12.26	3.14	0.86
parietal lobe, adult, pool1	10034-101E7	204.70	8.72	10.40	4.41	1.50
parietal lobe, fetal, donor1	10072-101I9	247.31	15.52	22.31	10.67	3.88
parietal lobe, newborn, donor10223	10356-105E5	137.58	11.59	8.22	3.36	1.50
parotid gland, adult	10199-103F1	122.10	5.55	5.55	4.32	0.00
penis, adult	10200-103F2	100.98	3.22	3.22	1.07	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	159.72	37.19	11.34	4.28	2.97
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	44.44	4.23	2.91	2.33	0.58
pineal gland - adult, donor10196	10179-103C8	160.61	0.00	12.26	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	249.91	2.37	17.17	1.18	1.18
pineal gland, adult, donor10258	10377-105G8	125.41	0.00	15.68	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	147.72	22.26	12.14	8.09	5.06
pituitary gland, adult, donor10252	10162-103A9	322.61	23.97	17.72	7.30	1.04
pituitary gland, adult, donor10258	10378-105G9	117.47	33.20	18.73	9.36	3.40
placenta, adult, pool1	10021-101D3	114.06	3.76	5.81	0.97	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	86.74	21.59	5.96	5.56	1.85
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	112.99	2.96	4.51	0.62	0.16
pons, adult, pool1	10033-101E6	158.71	6.89	10.50	3.18	1.29
postcentral gyrus, adult, pool1	10032-101E5	209.05	8.11	10.55	5.75	1.74
promyelocytes/myelocytes PMC, donor1	12132-128D8	273.97	8.37	8.37	4.18	4.18
promyelocytes/myelocytes PMC, donor2	12136-128E3	27.54	27.54	5.51	0.00	11.02
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	23.47	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	84.92	16.17	4.52	6.55	1.89
prostate cancer cell line:PC-3	10439-106E7	172.24	34.85	6.35	9.98	1.45
prostate, adult, pool1	10022-101D4	101.48	5.26	5.17	3.81	0.54
putamen, adult, donor10196	10176-103C5	140.22	4.01	10.39	1.42	0.94
putamen, adult, donor10252	10152-102I8	133.33	3.92	7.84	1.96	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	126.77	12.02	0.00	4.37	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	113.56	2.17	10.39	0.72	0.97
putamen, newborn, donor10223	10365-105F5	107.20	4.50	5.25	2.25	0.00
rectal cancer cell line:TT1TKB	10469-106I1	80.59	5.24	5.53	1.45	0.29
rectum, fetal, donor1	10067-101I4	94.59	4.17	9.74	4.17	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	93.70	15.69	4.66	5.94	1.06
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	36.86	13.67	2.49	3.73	2.07
retina, adult, pool1	10030-101E3	164.80	4.17	7.45	3.28	0.99
retinoblastoma cell line:Y79	10475-106I7	47.02	1.30	2.08	0.26	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	102.29	14.38	2.95	3.81	0.98
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	82.39	8.72	3.66	1.69	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	132.62	5.30	6.06	3.03	0.00
salivary acinar cells, donor1	11771-123I7	78.01	10.68	3.88	5.02	0.97
salivary acinar cells, donor2	11772-123I8	100.37	10.33	5.09	4.82	2.89
salivary acinar cells, donor3	11773-123I9	104.60	4.63	5.30	3.31	1.32
salivary gland, adult, pool1	10093-102C3	160.15	4.00	5.72	3.43	2.29
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	75.80	16.19	7.25	6.49	2.19
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	64.65	12.58	5.88	6.70	1.41
seminal vesicle, adult	10201-103F3	150.79	1.59	13.23	1.06	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	66.56	12.15	6.56	3.16	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	85.81	4.78	3.77	4.03	1.26
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	161.57	21.07	8.03	5.02	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	189.66	30.89	5.64	4.03	0.67
signet ring carcinoma cell line:Kato III	10436-106E4	142.47	30.84	6.08	11.61	1.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	44.90	21.68	2.97	6.58	0.77
skeletal muscle - soleus muscle, donor1	10282-104F3	156.76	3.55	2.13	0.71	2.84
skeletal muscle, adult, pool1	10023-101D5	169.23	7.32	5.28	3.12	0.60
skeletal muscle, fetal, donor1	10066-101I3	80.40	2.01	6.03	0.00	3.02
skin, adult, donor1	10074-102A2	47.50	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	91.53	5.68	9.47	1.89	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	120.07	24.01	10.67	5.00	3.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	144.05	27.74	3.47	6.93	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	205.28	6.94	15.61	9.25	2.12
small cell lung carcinoma cell line:LK-2	10541-107H1	87.36	18.96	2.47	5.11	0.82
small cell lung carcinoma cell line:NCI-H82	10842-111E5	167.28	13.67	7.88	9.01	0.64
small cell lung carcinoma cell line:WA-hT	10562-108A4	126.39	20.05	4.14	2.83	3.70
small intestine, adult, pool1	10024-101D6	143.93	5.61	9.32	3.34	0.48
small intestine, fetal, donor1	10064-101I1	63.14	2.21	4.42	2.70	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	104.12	28.21	7.69	9.23	2.56
smooth muscle, adult, pool1	10048-101G3	75.47	2.07	4.91	2.07	1.03
somatostatinoma cell line:QGP-1	10781-110G7	54.41	5.36	2.68	3.22	1.07
spinal cord - adult, donor10196	10181-103D1	133.06	3.44	12.85	1.61	0.69
spinal cord, adult, donor10252	10159-103A6	152.98	5.13	5.91	2.76	1.58
spinal cord, adult, donor10258	10369-105F9	141.13	1.38	3.46	1.38	0.00
spinal cord, fetal, donor1	10056-101H2	154.90	8.54	11.59	1.22	2.44
spinal cord, newborn, donor10223	10359-105E8	172.20	8.73	7.81	4.59	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	76.47	9.11	4.63	1.79	1.19
spleen, adult, pool1	10025-101D7	94.83	18.61	6.17	3.52	1.10
spleen, fetal, pool1	10044-101F8	139.92	14.94	8.66	3.34	1.51
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	75.15	71.32	3.21	12.84	4.35
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	48.42	4.56	3.23	2.85	0.76
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	105.88	5.59	5.59	4.19	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	79.75	9.77	3.13	1.56	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	52.56	6.98	2.25	2.03	1.35
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	23.30	9.74	1.27	5.93	1.27
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	120.58	9.31	13.54	6.77	1.69
stomach, fetal, donor1	10062-101H8	96.12	3.20	4.27	0.00	1.07
submaxillary gland, adult	10202-103F4	101.97	3.99	6.27	2.28	0.57
substantia nigra - adult, donor10196	10178-103C7	162.82	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	188.18	6.65	6.02	3.95	1.45
substantia nigra, adult, donor10258	10371-105G2	173.28	6.21	4.14	1.03	1.03
substantia nigra, newborn, donor10223	10358-105E7	96.80	7.07	3.53	2.12	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	133.89	71.30	7.57	14.21	7.80
temporal lobe, adult, pool1	10031-101E4	232.95	8.82	13.56	6.02	2.29
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	295.59	8.55	27.78	4.27	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	328.33	7.91	17.58	4.40	3.96
tenocyte, donor1	11763-123H8	103.33	18.85	5.24	4.19	1.75
tenocyte, donor2	11765-123I1	74.39	6.10	5.72	2.67	1.53
tenocyte, donor3	11768-123I4	101.56	11.12	8.15	2.97	2.97
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	156.19	38.07	7.99	9.01	1.53
teratocarcinoma cell line:NCR-G1	10798-110I6	90.02	9.09	2.16	4.32	0.92
teratocarcinoma cell line:PA-1	10807-111A6	97.17	14.57	3.56	4.18	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	97.62	30.85	4.44	6.09	1.52
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	168.29	7.56	7.19	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	223.47	20.39	14.72	2.18	3.60
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	57.00	18.24	8.14	2.61	1.30
testis, adult, pool1	10026-101D8	120.15	26.31	10.09	3.11	0.75
testis, adult, pool2	10096-102C6	139.39	33.38	15.34	3.16	1.35
thalamus - adult, donor10196	10168-103B6	156.77	2.21	7.73	0.00	2.21
thalamus, adult, donor10252	10154-103A1	199.26	8.91	9.06	5.31	0.78
thalamus, adult, donor10258, tech_rep1	10370-105G1	152.42	1.54	1.54	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	69.66	6.59	6.92	2.14	0.99
thalamus, newborn, donor10223	10366-105F6	149.01	10.36	13.81	1.73	1.73
throat, adult	10209-103G2	105.36	5.24	6.49	3.75	1.00
throat, fetal, donor1	10061-101H7	113.66	5.48	11.58	3.35	1.52
thymic carcinoma cell line:Ty-82	10803-111A2	135.73	74.52	4.37	26.03	3.97
thymus, adult, pool1	10027-101D9	146.44	31.71	7.46	3.78	4.97
thymus, fetal, pool1	10043-101F7	181.42	21.09	8.21	2.29	3.64
thyroid carcinoma cell line:KHM-5M	10776-110G2	34.97	9.71	1.86	3.06	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	95.41	19.98	5.03	4.47	2.10
thyroid, adult, pool1	10028-101E1	208.93	20.44	11.20	7.84	1.40
thyroid, fetal, donor1	10060-101H6	123.13	8.44	6.86	3.16	1.32
tongue epidermis (fungiform papillae), donor1	10288-104F9	147.82	9.24	3.08	0.00	0.00
tongue, adult	10203-103F5	110.94	10.00	6.51	4.19	1.63
tongue, fetal, donor1	10059-101H5	86.70	5.52	3.55	4.34	1.58
tonsil, adult, pool1	10047-101G2	145.25	26.35	6.71	5.11	2.80
trachea, adult, pool1	10029-101E2	123.60	10.55	7.03	4.91	1.80
trachea, fetal, donor1	10058-101H4	96.94	10.00	9.23	1.54	1.92
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	128.96	12.75	8.15	4.61	2.13
transitional-cell carcinoma cell line:5637	10418-106C4	120.16	25.53	3.34	3.95	1.42
transitional-cell carcinoma cell line:JMSU1	10492-107B6	67.85	14.89	6.58	6.11	0.94
tridermal teratoma cell line:HGRT	10694-109G1	169.33	15.22	13.32	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	58.58	2.45	4.66	0.93	0.51
umbilical cord, fetal, donor1	10057-101H3	77.20	8.35	2.09	0.00	2.09
uterus, adult, pool1	10100-102D1	190.42	7.17	10.58	3.75	1.19
uterus, fetal, donor1	10055-101H1	135.66	9.21	12.29	6.14	0.51
vagina, adult	10204-103F6	141.52	4.52	10.99	2.58	0.00
vein, adult	10191-103E2	92.06	10.08	5.26	1.53	1.10
xeroderma pigentosum b cell line:XPL 17	10563-108A5	64.36	30.98	2.14	3.20	1.07